Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Teleflex Incorporated (TFX)
USD133.28
+3.12 (+2.40%)
US NYSE S&P 500
Healthcare Medical - Instruments & Supplies
Address
550 East Swedesford Road 19087-1603
Wayne, PA, US
Wayne, PA, US
CEO
Stuart A. Randle
Website
teleflex.com
IPO
1980-03-17
CIK 96943 ISIN US8793691069
Description
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
News Sentiment (7d)
Based on only 1 article — low confidence
- Teleflex Publishes 2025 Global Impact Report Business Wire
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Index membership
| Index | Added | Removed | Status |
|---|---|---|---|
| S&P 500 | 2019-01-17 | — | Active |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD133.28
+3.12 (+2.40%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
741.5K
Beta
0.82
Float Shares
44.03M
Free Float %
99.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.51% | +0.08% | +9.57% | +24.09% | +16.35% | +6.29% | +0.37% | -48.03% | -66.39% | -19.91% | +29,879.20% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (29 ratings, all time)
Buy
Price Targets & DCF
Current price
133.28
Low
116.00
-13.0%
Consensus
140.50
+5.4%
Median
143.50
+7.7%
High
155.00
+16.3%
DCF (Unlevered)
154.10
+15.6%
DCF (Levered)
129.15
-3.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
18% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 0 | 0 |
| Hold | 9 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | -1 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 2 |
137.50
+3.2%
|
| Last Year | 9 |
132.00
-1.0%
|
| All Time | 29 |
225.69
+69.3%
|
Quality scores
Altman Z-Score
1.42
Distress
Piotroski F-Score
6 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%-34.6% Q1'26: -21.8% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%-1,468.2% Q1'26: -108.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+3.0% Q1'26: +8.5% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+6.3% Q1'26: -5.1% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+2.3% Q1'26: -3.8% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%-5.0% ★ Q1'26: -3.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×9.01× Q1'26: -11.20× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2010 actual |
Dec 2011 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 9 Rev. Ana. 7 EPS Ana. |
Dec 2027 9 Rev. Ana. 7 EPS Ana. |
Dec 2028 6 Rev. Ana. 1 EPS Ana. |
Dec 2029 5 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.80B
est: 1.38B (+30.2%)
|
1.53B
est: 1.55B (-1.4%)
|
1.70B
est: 1.56B (+8.5%)
|
1.84B
est: 1.69B (+8.8%)
|
1.81B
est: 1.81B (+0.2%)
|
1.87B
est: 1.86B (+0.6%)
|
2.15B
est: 2.15B (-0.3%)
|
2.45B
est: 2.45B (0.0%)
|
2.60B
est: 2.59B (+0.1%)
|
2.54B
est: 2.51B (+0.9%)
|
2.81B
est: 2.80B (+0.5%)
|
2.79B
est: 2.79B (-0.1%)
|
2.97B
est: 3.01B (-1.1%)
|
3.05B
est: 3.08B (-1.0%)
|
1.99B
est: 3.30B (-39.6%)
|
2.29B
2.28B – 2.30B
-30.7% YoY
|
2.40B
2.39B – 2.42B
+5.0% YoY
|
2.52B
2.52B – 2.52B
+5.0% YoY
|
2.68B
2.66B – 2.69B
+6.1% YoY
|
2.82B
2.81B – 2.83B
+5.4% YoY
|
| EBITDA |
302.71M
est: 374.45M (-19.2%)
|
288.87M
est: 533.90M (-45.9%)
|
325.61M
est: 294.42M (+10.6%)
|
396.70M
est: 356.07M (+11.4%)
|
414.36M
est: 410.61M (+0.9%)
|
418.57M
est: 394.37M (+6.1%)
|
522.72M
est: 493.24M (+6.0%)
|
532.63M
est: 513.41M (+3.7%)
|
634.24M
est: 608.33M (+4.3%)
|
651.48M
est: 514.66M (+26.6%)
|
853.80M
est: 741.72M (+15.1%)
|
730.77M
est: 823.27M (-11.2%)
|
761.21M
est: 671.19M (+13.4%)
|
433.62M
est: 687.21M (-36.9%)
|
302.51M
est: 735.86M (-58.9%)
|
510.26M
508.03M – 512.18M
-30.7% YoY
|
535.57M
533.34M – 540.03M
+5.0% YoY
|
562.53M
562.03M – 563.03M
+5.0% YoY
|
596.92M
594.52M – 599.17M
+6.1% YoY
|
629.05M
626.53M – 631.42M
+5.4% YoY
|
| EBIT |
210.52M
est: 265.21M (-20.6%)
|
203.25M
est: 244.69M (-16.9%)
|
232.64M
est: 211.40M (+10.0%)
|
285.57M
est: 257.86M (+10.7%)
|
305.97M
est: 307.34M (-0.4%)
|
300.67M
est: 301.07M (-0.1%)
|
367.46M
est: 352.68M (+4.2%)
|
322.65M
est: 307.64M (+4.9%)
|
420.17M
est: 410.15M (+2.4%)
|
424.23M
est: 341.50M (+24.2%)
|
616.44M
est: 545.58M (+13.0%)
|
500.18M
est: 606.15M (-17.5%)
|
519.09M
est: 413.84M (+25.4%)
|
159.02M
est: 423.71M (-62.5%)
|
124.78M
est: 453.71M (-72.5%)
|
314.61M
313.24M – 315.80M
-30.7% YoY
|
330.22M
328.84M – 332.97M
+5.0% YoY
|
346.84M
346.53M – 347.15M
+5.0% YoY
|
368.04M
366.57M – 369.43M
+6.1% YoY
|
387.86M
386.30M – 389.32M
+5.4% YoY
|
| Net Income |
201.09M
est: 193.20M (+4.1%)
|
323.33M
est: 347.58M (-7.0%)
|
150.88M
est: 136.11M (+10.9%)
|
187.68M
est: 170.09M (+10.3%)
|
244.86M
est: 237.32M (+3.2%)
|
237.38M
est: 224.32M (+5.8%)
|
152.53M
est: 140.71M (+8.4%)
|
200.80M
est: 192.13M (+4.5%)
|
461.47M
est: 437.56M (+5.5%)
|
335.32M
est: 276.39M (+21.3%)
|
485.37M
est: 423.10M (+14.7%)
|
363.14M
est: 471.86M (-23.0%)
|
356.33M
est: 251.56M (+41.6%)
|
69.68M
est: 625.07M (-88.9%)
|
-905.64M
est: 626.24M (-244.6%)
|
324.95M
283.67M – 366.24M
-48.1% YoY
|
473.07M
374.61M – 571.53M
+45.6% YoY
|
529.38M
526.70M – 532.06M
+11.9% YoY
|
558.16M
555.24M – 560.89M
+5.4% YoY
|
594.83M
591.72M – 597.74M
+6.6% YoY
|
| SGA |
475.32M
est: 416.59M (+14.1%)
|
429.26M
est: 450.26M (-4.7%)
|
502.19M
est: 459.26M (+9.3%)
|
578.66M
est: 527.04M (+9.8%)
|
568.98M
est: 554.26M (+2.7%)
|
563.31M
est: 530.37M (+6.2%)
|
699.96M
est: 665.09M (+5.2%)
|
878.69M
est: 839.98M (+4.6%)
|
851.77M
est: 897.77M (-5.1%)
|
743.57M
est: 569.12M (+30.7%)
|
860.09M
est: 746.89M (+15.2%)
|
863.75M
est: 833.96M (+3.6%)
|
929.87M
est: 972.27M (-4.4%)
|
995.27M
est: 995.47M (0.0%)
|
720.17M
est: 1.07B (-32.4%)
|
739.15M
735.92M – 741.93M
-30.7% YoY
|
775.81M
772.57M – 782.27M
+5.0% YoY
|
814.87M
814.14M – 815.59M
+5.0% YoY
|
864.68M
861.21M – 867.94M
+6.1% YoY
|
911.22M
907.57M – 914.66M
+5.4% YoY
|
| EPS |
5.04
est: 3.63 (+38.8%)
|
7.98
est: 4.21 (+89.5%)
|
3.67
est: 4.17 (-12.0%)
|
4.54
est: 4.77 (-4.8%)
|
5.89
est: 6.25 (-5.7%)
|
5.48
est: 7.30 (-24.9%)
|
3.39
est: 8.36 (-59.4%)
|
4.39
est: 9.89 (-55.6%)
|
9.99
est: 11.08 (-9.9%)
|
7.21
est: 10.47 (-31.1%)
|
10.38
est: 13.26 (-21.7%)
|
7.74
est: 12.98 (-40.4%)
|
7.58
est: 5.63 (+34.7%)
|
1.49
est: 13.99 (-89.3%)
|
-20.30
est: 14.02 (-244.8%)
|
6.70
6.34 – 8.19
-52.2% YoY
|
10.49
8.38 – 12.78
+56.6% YoY
|
11.84
11.78 – 11.90
+12.8% YoY
|
12.48
12.41 – 12.54
+5.4% YoY
|
13.30
13.23 – 13.37
+6.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-01 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
205.76M
OE per share TTM
4.67
Owner's Yield
3.53%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
21.7%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
97
Total invested
346.97M
Insider transactions (90d)
0
Beneficial owners (>5%)
15
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 85-4328500 | 7.57M | 16.10% | 2.65M | — | 7.57M | — | IA | Maryland | 2022-08-10 | ↗ |
| 2 | The Vanguard Group - 23-1945930 | 5.06M | 10.81% | — | 74.8K | 4.87M | 189.4K | IA | — | 2022-02-10 | ↗ |
| 3 | (1) BlackRock, Inc. | 4.86M | 10.40% | 4.44M | — | 4.86M | — | HC | Delaware | 2022-01-27 | ↗ |
| 4 | EIN #00-0000000 | 4.83M | 10.30% | — | 4.83M | — | 4.83M | IA, HC | Jersey, Channel Islands | 2023-12-07 | ↗ |
| 5 | Wellington Group Holdings LLP | 3.33M | 7.11% | — | 2.99M | — | — | HC | Delaware | 2022-02-04 | ↗ |
| 6 | Wellington Investment Advisors Holdings LLP | 3.33M | 7.11% | — | 2.99M | — | — | HC | Delaware | 2022-02-04 | ↗ |
| 7 | Wellington Management Group LLP | 3.33M | 7.11% | — | 2.99M | — | — | HC | Massachusetts | 2022-02-04 | ↗ |
| 8 | Wellington Management Company LLP | 3.01M | 6.42% | — | 2.86M | — | — | IA | Delaware | 2022-02-04 | ↗ |
| 9 | Morgan Stanley | 2.53M | 5.40% | — | 13.00 | — | 2.52M | HC, CO | — | 2023-02-10 | ↗ |
| 10 | Eaton Vance Management 04-3101341 | 2.22M | 11.00% | 2.22M | — | 2.22M | — | IA | United States of America | 2020-02-13 | ↗ |
| 11 | Franklin Resources, Inc. (13-2670991) | 2.12M | 5.30% | — | — | — | — | HC | Delaware | 2005-02-14 | ↗ |
| 12 | 52-0556948 | 2.09M | 4.40% | 719.0K | — | 2.09M | — | IA | Maryland | 2022-08-10 | ↗ |
| 13 | George S. Loening | 1.78M | 3.90% | — | 1.78M | — | — | HC, IN | Delaware | 2018-02-14 | ↗ |
| 14 | Select Equity Group, L.P. | 1.78M | 3.90% | — | 1.78M | — | — | IA | Delaware | 2018-02-14 | ↗ |
| 15 | 94-2943858 | 1.67M | 4.05% | 1.67M | — | 1.67M | — | IA | U.S.A. | 2014-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
97
-313 vs prev Q
New positions
11
Closed positions
317
Increased
40
Reduced
38
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 257.6K +257.6K (+100.0%) | 31.43B +31.4B (+100.0%) | 0.58% +0.582 pp | 29.70% +29.699 pp | USD122.04 +0.0% | 1 qtrs NEW |
| 2 | BLACKROCK, INC. | 5.34M +2.1K (+0.0%) | 651.63M -1.4M (-0.2%) | 12.07% +0.412 pp | 0.01% 0.000 pp | USD209.35 -41.7% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 4.76M -37.8K (-0.8%) | 580.79M -6.1M (-1.0%) | 10.76% +0.281 pp | 0.01% 0.000 pp | USD176.10 -30.7% | 84 qtrs — |
| 4 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 4.36M -212.3K (-4.6%) | 531.70M -27.4M (-4.9%) | 9.85% -0.131 pp | 0.34% -0.006 pp | USD201.00 -39.3% | 14 qtrs — |
| 5 | JANUS HENDERSON GROUP PLC | 4.25M +84.8K (+2.0%) | 518.20M +9.0M (+1.8%) | 9.60% +0.509 pp | 0.23% 0.000 pp | USD254.59 -52.1% | 37 qtrs — |
| 6 | MORGAN STANLEY | 2.50M -311.7K (-11.1%) | 305.03M -38.9M (-11.3%) | 5.65% -0.490 pp | 0.02% -0.003 pp | USD240.07 -49.2% | 51 qtrs — |
| 7 | AQR CAPITAL MANAGEMENT LLC | 1.92M -442.9K (-18.7%) | 234.38M -53.2M (-18.5%) | 4.35% -0.821 pp | 0.12% -0.061 pp | USD133.37 -8.5% | 82 qtrs — |
| 8 | STATE STREET CORP | 1.48M +22.1K (+1.5%) | 180.47M +2.2M (+1.3%) | 3.34% +0.161 pp | 0.01% 0.000 pp | USD196.39 -37.9% | 51 qtrs — |
| 9 | DIMENSIONAL FUND ADVISORS LP | 1.25M +5.1K (+0.4%) | 152.63M +221.8K (+0.1%) | 2.83% +0.106 pp | 0.03% -0.001 pp | USD146.60 -16.8% | 51 qtrs — |
| 10 | COOKE & BIELER LP | 1.18M -37.5K (-3.1%) | 144.39M -5.0M (-3.3%) | 2.67% +0.008 pp | 1.51% -0.037 pp | USD202.71 -39.8% | 12 qtrs — |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 985.7K +94.7K (+10.6%) | 120.31M +11.3M (+10.3%) | 2.23% +0.282 pp | 0.01% +0.001 pp | USD230.12 -47.0% | 78 qtrs — |
| 12 | ABRAMS BISON INVESTMENTS, LLC | 969.0K +51.1K (+5.6%) | 118.26M +5.9M (+5.3%) | 2.19% +0.186 pp | 8.77% -0.038 pp | USD122.34 -0.2% | 2 qtrs — |
| 13 | THRIVENT FINANCIAL FOR LUTHERANS | 774.0K +223.6K (+40.6%) | 94.46M +27.1M (+40.3%) | 1.75% +0.547 pp | 0.17% +0.035 pp | USD125.21 -2.5% | 54 qtrs — |
| 14 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 750.0K +89.2K (+13.5%) | 91.53M +10.7M (+13.2%) | 1.70% +0.252 pp | 0.05% +0.003 pp | USD126.61 -3.6% | 4 qtrs — |
| 15 | FULLER & THALER ASSET MANAGEMENT, INC. | 697.0K +122.5K (+21.3%) | 85.06M +14.8M (+21.0%) | 1.58% +0.321 pp | 0.29% +0.048 pp | USD122.30 -0.2% | 2 qtrs — |
| 16 | MILLENNIUM MANAGEMENT LLC | 592.1K +386.5K (+188.0%) | 72.26M +47.1M (+187.3%) | 1.34% +0.890 pp | 0.03% +0.020 pp | USD143.85 -15.2% | 68 qtrs — |
| 17 | NORGES BANK | 541.4K +541.4K (+100.0%) | 66.08M +66.1M (+100.0%) | 1.22% +1.224 pp | 0.01% +0.007 pp | USD122.04 +0.0% | 1 qtrs NEW |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 501.1K -1.7K (-0.3%) | 61.15M -368.4K (-0.6%) | 1.13% +0.035 pp | 0.01% 0.000 pp | USD187.71 -35.0% | 100 qtrs — |
| 19 | BOSTON PARTNERS | 478.6K -134.3K (-21.9%) | 58.40M -16.6M (-22.1%) | 1.08% -0.257 pp | 0.06% -0.017 pp | USD135.89 -10.2% | 9 qtrs — |
| 20 | CAPITAL INTERNATIONAL INVESTORS | 455.8K +89.3K (+24.4%) | 55.63M +10.8M (+24.0%) | 1.03% +0.230 pp | 0.01% +0.002 pp | USD122.30 -0.2% | 2 qtrs — |
| 21 | BANK OF AMERICA CORP /DE/ | 419.0K -103.8K (-19.8%) | 51.13M -12.8M (-20.1%) | 0.95% -0.195 pp | 0.00% -0.001 pp | USD194.76 -37.3% | 52 qtrs — |
| 22 | WOLF HILL CAPITAL MANAGEMENT, LP | 388.4K +388.4K (+100.0%) | 47.41M +47.4M (+100.0%) | 0.88% +0.878 pp | 5.23% +5.234 pp | USD122.04 +0.0% | 1 qtrs NEW |
| 23 | PZENA INVESTMENT MANAGEMENT LLC | 379.5K -8.0K (-2.1%) | 46.31M -1.1M (-2.3%) | 0.86% +0.011 pp | 0.14% -0.015 pp | USD118.68 +2.8% | 3 qtrs — |
| 24 | DIAMOND HILL CAPITAL MANAGEMENT INC | 349.8K +20.8K (+6.3%) | 42.69M +2.4M (+6.0%) | 0.79% +0.072 pp | 0.22% +0.028 pp | USD154.03 -20.8% | 5 qtrs — |
| 25 | INVENOMIC CAPITAL MANAGEMENT LP | 346.6K -39.1K (-10.1%) | 42.29M -4.9M (-10.4%) | 0.78% -0.059 pp | 1.97% -0.316 pp | USD135.99 -10.3% | 5 qtrs — |
| 26 | HOLOCENE ADVISORS, LP | 342.9K +304.6K (+796.0%) | 41.85M +37.2M (+793.6%) | 0.78% +0.692 pp | 0.09% +0.077 pp | USD127.21 -4.1% | 7 qtrs — |
| 27 | WALLEYE CAPITAL LLC | 319.2K +233.1K (+270.8%) | 38.95M +28.4M (+269.9%) | 0.72% +0.534 pp | 0.12% +0.080 pp | USD122.37 -0.3% | 7 qtrs — |
| 28 | D. E. SHAW & CO., INC. | 312.7K -214.3K (-40.7%) | 38.16M -26.3M (-40.8%) | 0.71% -0.444 pp | 0.02% -0.016 pp | USD153.62 -20.6% | 7 qtrs — |
| 29 | TD ASSET MANAGEMENT INC | 304.4K -22.4K (-6.9%) | 37.15M -2.8M (-7.1%) | 0.69% -0.026 pp | 0.03% -0.003 pp | USD281.75 -56.7% | 51 qtrs — |
| 30 | NORTHERN TRUST CORP | 287.8K -16.5K (-5.4%) | 35.12M -2.1M (-5.7%) | 0.65% -0.014 pp | 0.00% 0.000 pp | USD163.40 -25.3% | 51 qtrs — |
| 31 | AMERIPRISE FINANCIAL INC | 265.7K -23.9K (-8.3%) | 32.43M -3.0M (-8.5%) | 0.60% -0.032 pp | 0.01% -0.001 pp | USD131.87 -7.5% | 56 qtrs — |
| 32 | BANK OF NEW YORK MELLON CORP | 262.7K -12.2K (-4.4%) | 32.06M -1.6M (-4.7%) | 0.59% -0.007 pp | 0.01% -0.001 pp | USD226.74 -46.2% | 66 qtrs — |
| 33 | MANGROVE PARTNERS | 256.7K +256.7K (+100.0%) | 31.33M +31.3M (+100.0%) | 0.58% +0.580 pp | 2.55% +2.553 pp | USD122.04 +0.0% | 1 qtrs NEW |
| 34 | WEDGE CAPITAL MANAGEMENT L L P/NC | 252.5K +32.5K (+14.8%) | 30.82M +3.9M (+14.5%) | 0.57% +0.090 pp | 0.55% +0.097 pp | USD122.32 -0.2% | 2 qtrs — |
| 35 | INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 250.0K +250.0K (+100.0%) | 30.51M +30.5M (+100.0%) | 0.57% +0.565 pp | 1.51% +1.515 pp | USD122.04 +0.0% | 1 qtrs NEW |
| 36 | UBS GROUP AG | 224.8K -173.9K (-43.6%) | 27.43M -21.3M (-43.8%) | 0.51% -0.363 pp | 0.00% -0.003 pp | USD143.10 -14.7% | 45 qtrs — |
| 37 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 221.1K -10.6K (-4.6%) | 26.98M -1.4M (-4.8%) | 0.50% -0.006 pp | 0.02% -0.001 pp | USD167.26 -27.0% | 51 qtrs — |
| 38 | PRINCIPAL FINANCIAL GROUP INC | 210.0K -2.0K (-0.9%) | 25.63M -308.1K (-1.2%) | 0.47% +0.012 pp | 0.01% +0.000 pp | USD157.99 -22.8% | 81 qtrs — |
| 39 | FREESTONE GROVE PARTNERS LP | 200.9K +22.0K (+12.3%) | 24.52M +2.6M (+12.0%) | 0.45% +0.064 pp | 0.18% +0.014 pp | USD131.90 -7.5% | 5 qtrs — |
| 40 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 193.0K +4.8K (+2.5%) | 23.55M +524.8K (+2.3%) | 0.44% +0.025 pp | 0.08% -0.005 pp | USD136.60 -10.7% | 28 qtrs — |
| 41 | HBK INVESTMENTS L P | 192.4K -7.5K (-3.8%) | 23.48M -984.2K (-4.0%) | 0.43% -0.002 pp | 0.18% -0.084 pp | USD122.36 -0.3% | 2 qtrs — |
| 42 | SOLEUS CAPITAL MANAGEMENT, L.P. | 190.0K +190.0K (+100.0%) | 23.19M +23.2M (+100.0%) | 0.43% +0.430 pp | 0.86% +0.855 pp | USD122.04 +0.0% | 1 qtrs NEW |
| 43 | QUBE RESEARCH & TECHNOLOGIES LTD | 174.8K -336.4K (-65.8%) | 21.34M -41.2M (-65.9%) | 0.40% -0.721 pp | 0.02% -0.043 pp | USD128.27 -4.9% | 4 qtrs — |
| 44 | FIRST TRUST ADVISORS LP | 163.7K +37.7K (+29.9%) | 19.98M +4.6M (+29.6%) | 0.37% +0.095 pp | 0.01% +0.003 pp | USD137.94 -11.5% | 50 qtrs — |
| 45 | INVESCO LTD. | 162.9K +4.8K (+3.0%) | 19.88M +536.1K (+2.8%) | 0.37% +0.023 pp | 0.00% +0.000 pp | USD215.82 -43.5% | 57 qtrs — |
| 46 | RUSSELL INVESTMENTS GROUP, LTD. | 134.7K +6.1K (+4.8%) | 16.44M +705.3K (+4.5%) | 0.30% +0.024 pp | 0.02% +0.000 pp | USD165.20 -26.1% | 37 qtrs — |
| 47 | MOORE CAPITAL MANAGEMENT, LP | 134.7K +30.3K (+29.0%) | 16.44M +3.7M (+28.6%) | 0.30% +0.076 pp | 0.24% +0.061 pp | USD141.40 -13.7% | 5 qtrs — |
| 48 | UBS ASSET MANAGEMENT AMERICAS INC | 130.8K -2.2K (-1.6%) | 15.96M -306.4K (-1.9%) | 0.30% +0.005 pp | 0.00% 0.000 pp | USD193.02 -36.8% | 55 qtrs — |
| 49 | WESTWOOD HOLDINGS GROUP INC | 130.1K -1.7K (-1.3%) | 15.87M -244.4K (-1.5%) | 0.29% +0.006 pp | 0.13% +0.014 pp | USD217.71 -43.9% | 9 qtrs — |
| 50 | FMR LLC | 126.6K +84.3K (+199.4%) | 15.45M +10.3M (+198.6%) | 0.29% +0.194 pp | 0.00% +0.001 pp | USD124.49 -2.0% | 54 qtrs — |
| 51 | SCHRODER INVESTMENT MANAGEMENT GROUP | 125.4K +20.6K (+19.7%) | 15.25M +2.6M (+20.7%) | 0.28% +0.055 pp | 0.01% +0.002 pp | USD137.73 -11.4% | 27 qtrs — |
| 52 | JPMORGAN CHASE & CO | 122.2K -1.1K (-0.9%) | 14.92M -174.9K (-1.2%) | 0.28% +0.007 pp | 0.00% +0.000 pp | USD198.43 -38.5% | 51 qtrs — |
| 53 | GREENHAVEN ASSOCIATES INC | 122.1K +122.1K (+100.0%) | 14.90M +14.9M (+100.0%) | 0.28% +0.276 pp | 0.24% +0.242 pp | USD122.04 +0.0% | 1 qtrs NEW |
| 54 | SEI INVESTMENTS CO | 119.5K +4.9K (+4.3%) | 14.59M +567.1K (+4.0%) | 0.27% +0.020 pp | 0.01% -0.001 pp | USD194.55 -37.3% | 45 qtrs — |
| 55 | EMPYREAN CAPITAL PARTNERS, LP | 118.0K +118.0K (+100.0%) | 14.40M +14.4M (+100.0%) | 0.27% +0.267 pp | 0.50% +0.502 pp | USD122.04 +0.0% | 1 qtrs NEW |
| 56 | GOLDMAN SACHS GROUP INC | 117.4K -27.6K (-19.0%) | 14.32M -3.4M (-19.2%) | 0.27% -0.051 pp | 0.00% 0.000 pp | USD204.40 -40.3% | 73 qtrs — |
| 57 | LEGAL & GENERAL GROUP PLC | 113.8K -20.6K (-15.3%) | 13.89M -2.6M (-15.5%) | 0.26% -0.036 pp | 0.00% -0.001 pp | USD240.24 -49.2% | 60 qtrs — |
| 58 | RHUMBLINE ADVISERS | 110.3K +1.7K (+1.6%) | 13.46M +176.2K (+1.3%) | 0.25% +0.012 pp | 0.01% +0.000 pp | USD200.65 -39.2% | 55 qtrs — |
| 59 | WELLS FARGO & COMPANY/MN | 107.6K +99.0K (+1,150.4%) | 13.13M +12.1M (+1,147.0%) | 0.24% +0.224 pp | 0.00% +0.002 pp | USD134.90 -9.5% | 57 qtrs — |
| 60 | WOODLINE PARTNERS LP | 104.9K +104.9K (+100.0%) | 12.80M +12.8M (+100.0%) | 0.24% +0.237 pp | 0.05% +0.050 pp | USD122.04 +0.0% | 1 qtrs NEW |
| 61 | HEARTLAND ADVISORS INC | 103.9K -46.1K (-30.7%) | 12.68M -5.7M (-30.9%) | 0.23% -0.093 pp | 0.68% -0.287 pp | USD149.27 -18.2% | 6 qtrs — |
| 62 | MARATHON ASSET MANAGEMENT LTD | 102.9K +38.1K (+58.8%) | 12.56M +4.6M (+58.4%) | 0.23% +0.091 pp | 0.48% +0.192 pp | USD246.22 -50.4% | 17 qtrs — |
| 63 | DEUTSCHE BANK AG\ | 102.5K +20.8K (+25.5%) | 12.50M +2.5M (+25.2%) | 0.23% +0.053 pp | 0.00% +0.001 pp | USD215.30 -43.3% | 50 qtrs — |
| 64 | PFM HEALTH SCIENCES, LP | 102.4K +102.4K (+100.0%) | 12.50M +12.5M (+100.0%) | 0.23% +0.232 pp | 1.25% +1.246 pp | USD122.04 +0.0% | 1 qtrs NEW |
| 65 | ROYCE & ASSOCIATES LP | 92.0K +22.0K (+31.5%) | 11.23M +2.7M (+31.1%) | 0.21% +0.055 pp | 0.11% +0.029 pp | USD122.28 -0.2% | 2 qtrs — |
| 66 | IEQ CAPITAL, LLC | 89.9K -48.1K (-34.8%) | 10.98M -5.9M (-35.0%) | 0.20% -0.098 pp | 0.03% -0.018 pp | USD128.57 -5.1% | 25 qtrs — |
| 67 | BALYASNY ASSET MANAGEMENT L.P. | 87.7K +87.7K (+100.0%) | 10.70M +10.7M (+100.0%) | 0.20% +0.198 pp | 0.01% +0.014 pp | USD122.04 +0.0% | 10 qtrs — |
| 68 | SWISS NATIONAL BANK | 87.2K +1.5K (+1.8%) | 10.64M +155.6K (+1.5%) | 0.20% +0.010 pp | 0.01% +0.000 pp | USD223.95 -45.5% | 51 qtrs — |
| 69 | SIO CAPITAL MANAGEMENT, LLC | 86.9K +46.8K (+116.9%) | 10.60M +5.7M (+116.3%) | 0.20% +0.109 pp | 1.67% +0.427 pp | USD122.19 -0.1% | 10 qtrs — |
| 70 | FIRST EAGLE INVESTMENT MANAGEMENT, LLC | 84.3K +52.3K (+163.4%) | 10.29M +6.4M (+162.7%) | 0.19% +0.121 pp | 0.02% +0.011 pp | USD122.16 -0.1% | 2 qtrs — |
| 71 | SPEECE THORSON CAPITAL GROUP INC | 83.6K -5.2K (-5.8%) | 10.20M -657.0K (-6.0%) | 0.19% -0.005 pp | 2.21% +0.039 pp | USD196.15 -37.8% | 12 qtrs — |
| 72 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 81.8K -19.0 (0.0%) | 9.98M -28.5K (-0.3%) | 0.18% +0.006 pp | 0.01% 0.000 pp | USD210.06 -41.9% | 55 qtrs — |
| 73 | ADAR1 CAPITAL MANAGEMENT, LLC | 80.6K +80.6K (+100.0%) | 9.84M +9.8M (+100.0%) | 0.18% +0.182 pp | 0.72% +0.723 pp | USD122.04 +0.0% | 1 qtrs NEW |
| 74 | TEJARA CAPITAL LTD | 77.7K +69.7K (+871.3%) | 9.48M +8.5M (+868.7%) | 0.18% +0.158 pp | 2.23% +1.721 pp | USD122.07 0.0% | 2 qtrs — |
| 75 | QUANTINNO CAPITAL MANAGEMENT LP | 77.0K +32.5K (+73.0%) | 9.40M +4.0M (+72.5%) | 0.17% +0.077 pp | 0.02% +0.004 pp | USD125.52 -2.8% | 12 qtrs — |
| 76 | ARROWMARK COLORADO HOLDINGS LLC | 76.0K +26.0K (+52.0%) | 9.28M +3.2M (+51.6%) | 0.17% +0.063 pp | 0.20% +0.091 pp | USD122.25 -0.2% | 2 qtrs — |
| 77 | CERITY PARTNERS LLC | 73.5K -8.7K (-10.6%) | 8.97M -1.1M (-10.8%) | 0.17% -0.013 pp | 0.01% -0.003 pp | USD132.80 -8.1% | 33 qtrs — |
| 78 | RODGERS BROTHERS INC. | 68.3K +53.4K (+359.5%) | 8.34M +6.5M (+358.3%) | 0.15% +0.122 pp | 1.00% +0.774 pp | USD126.37 -3.4% | 53 qtrs — |
| 79 | CITADEL ADVISORS LLC | 65.6K -127.9K (-66.1%) | 8.00M -15.7M (-66.2%) | 0.15% -0.274 pp | 0.00% -0.002 pp | USD177.65 -31.3% | 7 qtrs — |
| 80 | NUVEEN, LLC | 64.7K +— (+0.0%) | 7.89M -20.7K (-0.3%) | 0.15% +0.005 pp | 0.00% +0.000 pp | USD138.19 -11.7% | 4 qtrs — |
| 81 | LAZARD ASSET MANAGEMENT LLC | 64.3K -4.0K (-5.9%) | 7.85M -514.1K (-6.1%) | 0.15% -0.004 pp | 0.01% +0.002 pp | USD125.65 -2.9% | 17 qtrs — |
| 82 | LSV ASSET MANAGEMENT | 63.6K +55.5K (+685.2%) | 7.76M +6.8M (+683.2%) | 0.14% +0.126 pp | 0.02% +0.015 pp | USD122.08 0.0% | 2 qtrs — |
| 83 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 59.6K +59.1K (+11,780.5%) | 7.28M +7.2M (+11,831.1%) | 0.13% +0.134 pp | 0.01% +0.008 pp | USD122.01 +0.0% | 14 qtrs — |
| 84 | FEDERATED HERMES, INC. | 59.3K -355.0 (-0.6%) | 7.24M -62.4K (-0.9%) | 0.13% +0.004 pp | 0.01% -0.001 pp | USD231.94 -47.4% | 54 qtrs — |
| 85 | CWM, LLC | 57.1K -15.2K (-21.0%) | 6.97M -1.9M (-21.2%) | 0.13% -0.029 pp | 0.02% -0.008 pp | USD129.00 -5.4% | 17 qtrs — |
| 86 | NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 46.8K +1.7K (+3.8%) | 5.71M +193.0K (+3.5%) | 0.11% +0.007 pp | 0.01% +0.000 pp | USD112.26 +8.7% | 51 qtrs — |
| 87 | BECKER CAPITAL MANAGEMENT INC | 43.4K -4.3K (-9.1%) | 5.29M -542.3K (-9.3%) | 0.10% -0.006 pp | 0.15% -0.019 pp | USD142.21 -14.2% | 5 qtrs — |
| 88 | BAADER BANK AKTIENGESELLSCHAFT | 43.3K +10.6K (+32.4%) | 5.29M +1.3M (+32.0%) | 0.10% +0.027 pp | 0.36% +0.103 pp | USD122.28 -0.2% | 2 qtrs — |
| 89 | RUFFER LLP | 42.2K +42.2K (+100.0%) | 5.15M +5.2M (+100.0%) | 0.10% +0.095 pp | 0.23% +0.235 pp | USD122.04 +0.0% | 1 qtrs NEW |
| 90 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 41.8K -69.0 (-0.2%) | 5.10M -21.8K (-0.4%) | 0.09% +0.003 pp | 0.01% 0.000 pp | USD151.06 -19.2% | 52 qtrs — |
| 91 | PRUDENTIAL FINANCIAL INC | 40.8K -1.6K (-3.8%) | 4.98M -212.1K (-4.1%) | 0.09% 0.000 pp | 0.01% 0.000 pp | USD262.74 -53.6% | 85 qtrs — |
| 92 | EDGESTREAM PARTNERS, L.P. | 40.3K +23.8K (+143.6%) | 4.92M +2.9M (+142.9%) | 0.09% +0.055 pp | 0.14% +0.079 pp | USD122.17 -0.1% | 7 qtrs — |
| 93 | PRICE T ROWE ASSOCIATES INC /MD/ | 39.2K +1.6K (+4.3%) | 4.78M +187.0K (+4.1%) | 0.09% +0.007 pp | 0.00% +0.000 pp | USD223.72 -45.4% | 75 qtrs — |
| 94 | GREAT WEST LIFE ASSURANCE CO /CAN/ | 38.5K +613.0 (+1.6%) | 4.70M +128.0K (+2.8%) | 0.09% +0.004 pp | 0.01% +0.002 pp | USD177.57 -31.3% | 49 qtrs — |
| 95 | COMERICA BANK | 37.7K +4.9K (+14.9%) | 4.60M +585.3K (+14.6%) | 0.09% +0.014 pp | 0.02% +0.003 pp | USD142.08 -14.1% | 10 qtrs — |
| 96 | BESSEMER GROUP INC | 36.6K +32.6K (+804.4%) | 4.47M +4.0M (+802.6%) | 0.08% +0.074 pp | 0.01% +0.006 pp | USD137.23 -11.1% | 43 qtrs — |
| 97 | JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 265.0K +265.0K (+100.0%) | 1.77M +1.8M (+100.0%) | 0.60% +0.599 pp | 1.32% +1.321 pp | USD122.04 +0.0% | 1 qtrs NEW |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 157 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco S&P SmallCap Health Care ETF PSCH | 2.62% | 4.29M | 0.29% |
| 2 | Brandes U.S. Small-Mid Cap Value ETF BSMC | 1.79% | 2.90M | 0.70% |
| 3 | State Street SPDR S&P Health Care Equipment ETF XHE | 1.61% | 2.43M | 0.35% |
| 4 | iShares U.S. Medical Devices ETF IHI | 0.90% | 28.12M | 0.38% |
| 5 | Goldman Sachs Small Cap Equity ETF GSC | 0.79% | 2.27M | 0.80% |
| 6 | Point Bridge America First ETF MAGA | 0.74% | 230.4K | 0.72% |
| 7 | Vanguard S&P Small-Cap 600 Value ETF VIOV | 0.66% | 12.58M | 0.10% |
| 8 | State Street SPDR S&P 600 Small Cap Value ETF SLYV | 0.65% | 31.61M | 0.15% |
| 9 | iShares S&P Small-Cap 600 Value ETF IJS | 0.65% | 52.32M | 0.18% |
| 10 | iShares US Medical Devices UCITS ETF USD UMDV.AS | 0.62% | 1.06M | 0.25% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.13
Bullish
Ratio by volume
3.00
Bullish
Buys
17
Sells
8
Shares acquired
147.9K
Shares disposed
2.5K
Cash buys
—
Cash sales
—
Net activity
+145,413
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-01 | Reterski Dominik Michal | Officer | — | — | Common Stock | 0 | 0.00 | — | 7,198 | D | ↗ |
| 2026-03-04 | Winters James | Officer | F-InKind | D | Common Stock | 247 | 119.18 | 29.4K | 17,760 | D | ↗ |
| 2026-03-04 | Logue Daniel V. | Officer | F-InKind | D | Common Stock | 131 | 119.18 | 15.6K | 24,653 | D | ↗ |
| 2026-03-04 | Hicks Cameron P | Officer | F-InKind | D | Common Stock | 98 | 119.18 | 11.7K | 19,363 | D | ↗ |
| 2026-03-04 | Deren John | Officer | F-InKind | D | Common Stock | 229 | 119.18 | 27.3K | 18,073 | D | ↗ |
| 2026-03-03 | Winters James | Officer | A-Award | A | Common Stock | 3,262 | 0.00 | — | 8,262 | D | ↗ |
| 2026-03-03 | Logue Daniel V. | Officer | A-Award | A | Stock Option / (Right to Buy) | 21,510 | 122.19 | 2.63M | 21,510 | D | ↗ |
| 2026-03-03 | Hicks Cameron P | Officer | A-Award | A | Stock Option / (Right to Buy) | 16,133 | 122.19 | 1.97M | 16,133 | D | ↗ |
| 2026-03-03 | Deren John | Officer | A-Award | A | Common Stock | 4,604 | 0.00 | — | 9,122 | D | ↗ |
| 2026-02-28 | Winters James | Officer | F-InKind | D | Common Stock | 661 | 122.06 | 80.7K | 5,000 | D | ↗ |
| 2026-02-28 | Logue Daniel V. | Officer | F-InKind | D | Common Stock | 484 | 122.06 | 59.1K | 14,931 | D | ↗ |
| 2026-02-28 | Hicks Cameron P | Officer | F-InKind | D | Common Stock | 396 | 122.06 | 48.3K | 11,365 | D | ↗ |
| 2026-02-28 | Deren John | Officer | F-InKind | D | Common Stock | 231 | 122.06 | 28.2K | 4,518 | D | ↗ |
| 2026-02-23 | Winters James | Officer | A-Award | A | Common Stock | 354 | 0.00 | — | 5,661 | D | ↗ |
| 2026-02-23 | Logue Daniel V. | Officer | A-Award | A | Common Stock | 443 | 0.00 | — | 15,415 | D | ↗ |
| 2026-02-23 | Hicks Cameron P | Officer | A-Award | A | Common Stock | 352 | 0.00 | — | 11,760 | D | ↗ |
| 2026-02-23 | Deren John | Officer | A-Award | A | Common Stock | 161 | 0.00 | — | 4,749 | D | ↗ |
| 2026-01-13 | RANDLE STUART A | Director / Officer | A-Award | A | Common Stock | 12,325 | 0.00 | — | 19,872 | D | ↗ |
| 2025-08-06 | HAGGERTY GRETCHEN R | Director | P-Purchase | A | Common Stock | 300 | 114.73 | 34.4K | 6,305 | D | ↗ |
| 2025-08-05 | Ryu Jaewon | Director | P-Purchase | A | Common Stock | 1,500 | 115.00 | 172.5K | 3,727 | D | ↗ |
| 2025-08-05 | RANDLE STUART A | Director | P-Purchase | A | Common Stock | 1,000 | 115.86 | 115.9K | 7,547 | D | ↗ |
| 2025-08-05 | Krakauer Andrew A | Director | P-Purchase | A | Common Stock | 1,000 | 115.25 | 115.3K | 7,192 | D | ↗ |
| 2025-08-05 | Kelly Liam | Director / Officer | P-Purchase | A | Common Stock | 1,500 | 115.07 | 172.6K | 45,267 | D | ↗ |
| 2025-05-09 | Ryu Jaewon | Director | A-Award | A | Stock Option / (Right to Buy) | 2,226 | 125.11 | 278.5K | 2,226 | D | ↗ |
| 2025-05-09 | RANDLE STUART A | Director | A-Award | A | Common Stock | 1,051 | 0.00 | — | 6,547 | D | ↗ |
| 2025-05-09 | Patil Neena M | Director | A-Award | A | Common Stock | 1,051 | 0.00 | — | 2,626 | D | ↗ |
| 2025-05-09 | Krakauer Andrew A | Director | A-Award | A | Stock Option / (Right to Buy) | 2,226 | 125.11 | 278.5K | 2,226 | D | ↗ |
| 2025-05-09 | Klasko Stephen K. M.D. | Director | A-Award | A | Stock Option / (Right to Buy) | 2,226 | 125.11 | 278.5K | 2,226 | D | ↗ |
| 2025-05-09 | HEINMILLER JOHN C | Director | A-Award | A | Stock Option / (Right to Buy) | 2,226 | 125.11 | 278.5K | 2,226 | D | ↗ |
| 2025-05-09 | HAGGERTY GRETCHEN R | Director | A-Award | A | Stock Option / (Right to Buy) | 2,226 | 125.11 | 278.5K | 2,226 | D | ↗ |
| 2025-05-09 | Duncan Candace H | Director | A-Award | A | Stock Option / (Right to Buy) | 2,226 | 125.11 | 278.5K | 4,452 | D | ↗ |
| 2025-05-05 | Duncan Candace H | Director | M-Exempt | D | Stock Option / (Right to Buy) | 4,833 | 123.04 | 594.7K | 0 | D | ↗ |
| 2025-04-01 | POWELL THOMAS E | Officer | F-InKind | D | Common Stock | 468 | 140.30 | 65.7K | 21,467 | D | ↗ |
| 2025-03-04 | Winters James | Officer | A-Award | A | Stock Option / (Right to Buy) | 13,387 | 130.79 | 1.75M | 13,387 | D | ↗ |
| 2025-03-04 | White Jay | Officer | A-Award | A | Common Stock | 1,896 | 0.00 | — | 7,761 | D | ↗ |
| 2025-03-04 | POWELL THOMAS E | Officer | A-Award | A | Common Stock | 5,664 | 0.00 | — | 21,935 | D | ↗ |
| 2025-03-04 | Logue Daniel V. | Officer | A-Award | A | Common Stock | 1,896 | 0.00 | — | 14,972 | D | ↗ |
| 2025-03-04 | Kelly Liam | Director / Officer | A-Award | A | Common Stock | 10,195 | 0.00 | — | 43,767 | D | ↗ |
| 2025-03-04 | Hicks Cameron P | Officer | A-Award | A | Stock Option / (Right to Buy) | 10,040 | 130.79 | 1.31M | 10,040 | D | ↗ |
| 2025-03-04 | Deren John | Officer | A-Award | A | Common Stock | 2,676 | 0.00 | — | 4,588 | D | ↗ |
| 2025-03-01 | Winters James | Officer | F-InKind | D | Common Stock | 434 | 132.75 | 57.6K | 3,411 | D | ↗ |
| 2025-03-01 | White Jay | Officer | F-InKind | D | Common Stock | 415 | 132.75 | 55.1K | 5,865 | D | ↗ |
| 2025-03-01 | POWELL THOMAS E | Officer | F-InKind | D | Common Stock | 900 | 132.75 | 119.5K | 16,271 | D | ↗ |
| 2025-03-01 | Logue Daniel V. | Officer | F-InKind | D | Common Stock | 228 | 132.75 | 30.3K | 13,076 | D | ↗ |
| 2025-03-01 | Kelly Liam | Director / Officer | F-InKind | D | Common Stock | 2,081 | 132.75 | 276.3K | 33,572 | D | ↗ |
| 2025-03-01 | Hicks Cameron P | Officer | F-InKind | D | Common Stock | 260 | 132.75 | 34.5K | 9,986 | D | ↗ |
| 2025-03-01 | Deren John | Officer | F-InKind | D | Common Stock | 157 | 132.75 | 20.8K | 1,912 | D | ↗ |
| 2025-02-24 | Winters James | Officer | A-Award | A | Common Stock | 195 | 0.00 | — | 3,845 | D | ↗ |
| 2025-02-24 | White Jay | Officer | A-Award | A | Common Stock | 305 | 0.00 | — | 6,280 | D | ↗ |
| 2025-02-24 | POWELL THOMAS E | Officer | A-Award | A | Common Stock | 531 | 0.00 | — | 17,171 | D | ↗ |
| 2025-02-24 | Logue Daniel V. | Officer | A-Award | A | Common Stock | 171 | 0.00 | — | 13,304 | D | ↗ |
| 2025-02-24 | Kelly Liam | Director / Officer | A-Award | A | Common Stock | 1,317 | 0.00 | — | 35,653 | D | ↗ |
| 2025-02-24 | Hicks Cameron P | Officer | A-Award | A | Common Stock | 185 | 0.00 | — | 10,246 | D | ↗ |
| 2025-02-24 | Deren John | Officer | A-Award | A | Common Stock | 92 | 0.00 | — | 2,069 | D | ↗ |
| 2025-02-20 | Logue Daniel V. | Officer | M-Exempt | A | Common Stock | 1,620 | 121.00 | 196.0K | 14,328 | D | ↗ |
| 2025-02-20 | Klasko Stephen K. M.D. | Director | M-Exempt | D | Stock Option / (Right to Buy) | 2,674 | 121.00 | 323.6K | 0 | D | ↗ |
| 2025-02-19 | Kelly Liam | Director / Officer | M-Exempt | D | Stock Option / (Right to Buy) | 29,084 | 121.00 | 3.52M | 0 | D | ↗ |
| 2024-08-24 | Deren John | Officer | F-InKind | D | Common Stock | 16 | 242.41 | 3.9K | 1,977 | — | ↗ |
| 2024-08-16 | RANDLE STUART A | Director | M-Exempt | A | Common Stock | 2,674 | 121.00 | 323.6K | 8,170 | — | ↗ |
| 2024-06-18 | Winters James | Officer | A-Award | A | Stock Option / (Right to Buy) | 1,676 | 202.09 | 338.7K | 1,676 | — | ↗ |
| 2024-05-07 | Ryu Jaewon | Director | A-Award | A | Stock Option / (Right to Buy) | 1,349 | 201.52 | 271.9K | 1,349 | — | ↗ |
| 2024-05-07 | RANDLE STUART A | Director | A-Award | A | Common Stock | 649 | 0.00 | — | 5,496 | — | ↗ |
| 2024-05-07 | Patil Neena M | Director | A-Award | A | Common Stock | 649 | 0.00 | — | 1,575 | — | ↗ |
| 2024-05-07 | Krakauer Andrew A | Director | A-Award | A | Stock Option / (Right to Buy) | 1,349 | 201.52 | 271.9K | 1,349 | — | ↗ |
| 2024-05-07 | Klasko Stephen K. M.D. | Director | A-Award | A | Common Stock | 838 | 0.00 | — | 7,137 | — | ↗ |
| 2024-05-07 | HEINMILLER JOHN C | Director | A-Award | A | Common Stock | 649 | 0.00 | — | 3,125 | — | ↗ |
| 2024-05-07 | HAGGERTY GRETCHEN R | Director | A-Award | A | Stock Option / (Right to Buy) | 1,349 | 201.52 | 271.9K | 1,349 | — | ↗ |
| 2024-05-07 | Duncan Candace H | Director | A-Award | A | Stock Option / (Right to Buy) | 1,349 | 201.52 | 271.9K | 1,349 | — | ↗ |
| 2024-03-05 | Hicks Cameron P | Officer | M-Exempt | A | Common Stock | 4,400 | 144.79 | 637.1K | 17,451 | — | ↗ |
| 2024-03-02 | Winters James | Officer | F-InKind | D | Common Stock | 305 | 223.00 | 68.0K | 3,395 | — | ↗ |
| 2024-03-02 | White Jay | Officer | F-InKind | D | Common Stock | 239 | 223.00 | 53.3K | 5,960 | — | ↗ |
| 2024-03-02 | POWELL THOMAS E | Officer | F-InKind | D | Common Stock | 810 | 223.00 | 180.6K | 16,615 | — | ↗ |
| 2024-03-02 | Logue Daniel V. | Officer | F-InKind | D | Common Stock | 149 | 223.00 | 33.2K | 12,694 | — | ↗ |
| 2024-03-02 | Kelly Liam | Director / Officer | F-InKind | D | Common Stock | 1,840 | 223.00 | 410.3K | 26,984 | — | ↗ |
| 2024-03-02 | Hicks Cameron P | Officer | F-InKind | D | Common Stock | 216 | 225.00 | 48.6K | 10,050 | — | ↗ |
| 2024-03-02 | Deren John | Officer | F-InKind | D | Common Stock | 137 | 223.00 | 30.6K | 1,988 | — | ↗ |
| 2024-02-27 | Winters James | Officer | A-Award | A | Common Stock | 1,114 | 0.00 | — | 3,700 | — | ↗ |
| 2024-02-27 | White Jay | Officer | A-Award | A | Stock Option / (Right to Buy) | 9,612 | 226.04 | 2.17M | 9,612 | — | ↗ |
| 2024-02-27 | POWELL THOMAS E | Officer | A-Award | A | Common Stock | 2,373 | 0.00 | — | 17,425 | — | ↗ |
| 2024-02-27 | Logue Daniel V. | Officer | A-Award | A | Common Stock | 1,317 | 0.00 | — | 12,843 | — | ↗ |
| 2024-02-27 | Kelly Liam | Director / Officer | A-Award | A | Common Stock | 6,787 | 0.00 | — | 28,824 | — | ↗ |
| 2024-02-27 | Hicks Cameron P | Officer | A-Award | A | Stock Option / (Right to Buy) | 6,999 | 226.04 | 1.58M | 6,999 | — | ↗ |
| 2024-02-27 | Deren John | Officer | A-Award | A | Common Stock | 417 | 0.00 | — | 2,125 | — | ↗ |
| 2024-02-26 | Logue Daniel V. | Officer | M-Exempt | D | Stock Option / (Right to Buy) | 1,525 | 101.12 | 154.2K | 0 | — | ↗ |
| 2024-02-19 | Winters James | Officer | A-Award | A | Common Stock | 194 | 0.00 | — | 2,586 | — | ↗ |
| 2024-02-19 | White Jay | Officer | A-Award | A | Common Stock | 251 | 0.00 | — | 4,843 | — | ↗ |
| 2024-02-19 | POWELL THOMAS E | Officer | A-Award | A | Common Stock | 668 | 0.00 | — | 15,052 | — | ↗ |
| 2024-02-19 | Logue Daniel V. | Officer | A-Award | A | Common Stock | 162 | 0.00 | — | 10,753 | — | ↗ |
| 2024-02-19 | Kelly Liam | Director / Officer | A-Award | A | Common Stock | 1,856 | 0.00 | — | 22,037 | — | ↗ |
| 2024-02-19 | Hicks Cameron P | Officer | A-Award | A | Common Stock | 232 | 0.00 | — | 9,277 | — | ↗ |
| 2024-02-19 | Deren John | Officer | A-Award | A | Common Stock | 113 | 0.00 | — | 1,708 | — | ↗ |
| 2023-12-27 | Kelly Liam | Director / Officer | M-Exempt | A | Common Stock | 3,081 | 107.47 | 331.1K | 44,726 | — | ↗ |
| 2023-12-21 | Kelly Liam | Director / Officer | G-Gift | A | Common Stock | 5,786 | 0.00 | — | 19,317 | — | ↗ |
| 2023-12-13 | Klasko Stephen K. M.D. | Director | F-InKind | D | Common Stock | 1,296 | 235.89 | 305.7K | 6,288 | — | ↗ |
| 2023-11-29 | POWELL THOMAS E | Officer | M-Exempt | A | Common Stock | 4,613 | 123.04 | 567.6K | 28,336 | — | ↗ |
| 2023-08-09 | Kelly Liam | Director / Officer | G-Gift | A | Common Stock | 5,768 | 0.00 | — | 5,768 | — | ↗ |
| 2023-05-10 | RANDLE STUART A | Director | M-Exempt | D | Stock Option / (Right to Buy) | 3,021 | 101.12 | 305.5K | 0 | — | ↗ |
| 2023-05-09 | Ryu Jaewon | Director | A-Award | A | Common Stock | 527 | 0.00 | — | 527 | — | ↗ |
| 2023-05-09 | RANDLE STUART A | Director | A-Award | A | Stock Option / (Right to Buy) | 1,076 | 251.99 | 271.1K | 1,076 | — | ↗ |
| 2023-05-09 | Patil Neena M | Director | A-Award | A | Stock Option / (Right to Buy) | 1,076 | 251.99 | 271.1K | 1,076 | — | ↗ |
| 2023-05-09 | Krakauer Andrew A | Director | A-Award | A | Stock Option / (Right to Buy) | 1,076 | 251.99 | 271.1K | 1,076 | — | ↗ |
| 2023-05-09 | Klasko Stephen K. M.D. | Director | A-Award | A | Stock Option / (Right to Buy) | 1,076 | 251.99 | 271.1K | 1,076 | — | ↗ |
| 2023-05-09 | HEINMILLER JOHN C | Director | A-Award | A | Stock Option / (Right to Buy) | 1,076 | 251.99 | 271.1K | 1,076 | — | ↗ |
| 2023-05-09 | HAGGERTY GRETCHEN R | Director | A-Award | A | Common Stock | 527 | 0.00 | — | 4,105 | — | ↗ |
| 2023-05-09 | Duncan Candace H | Director | A-Award | A | Stock Option / (Right to Buy) | 1,076 | 251.99 | 271.1K | 1,076 | — | ↗ |
| 2023-05-05 | Ryu Jaewon | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-02-28 | Winters James | Officer | A-Award | A | Common Stock | 912 | 0.00 | — | 2,392 | — | ↗ |
| 2023-02-28 | White Jay | Officer | A-Award | A | Common Stock | 1,347 | 0.00 | — | 4,592 | — | ↗ |
| 2023-02-28 | POWELL THOMAS E | Officer | A-Award | A | Common Stock | 2,357 | 0.00 | — | 14,384 | — | ↗ |
| 2023-02-28 | Logue Daniel V. | Officer | A-Award | A | Stock Option / (Right to Buy) | 7,938 | 238.23 | 1.89M | 7,938 | — | ↗ |
| 2023-02-28 | Kelly Liam | Director / Officer | A-Award | A | Common Stock | 5,050 | 0.00 | — | 24,238 | — | ↗ |
| 2023-02-28 | Hicks Cameron P | Officer | A-Award | A | Stock Option / (Right to Buy) | 6,314 | 238.23 | 1.50M | 6,314 | — | ↗ |
| 2023-02-28 | Deren John | Officer | A-Award | A | Common Stock | 414 | 0.00 | — | 1,595 | — | ↗ |
| 2023-02-25 | Winters James | Officer | F-InKind | D | Common Stock | 173 | 235.18 | 40.7K | 1,480 | — | ↗ |
| 2023-02-25 | White Jay | Officer | F-InKind | D | Common Stock | 135 | 235.18 | 31.7K | 3,245 | — | ↗ |
| 2023-02-25 | POWELL THOMAS E | Officer | F-InKind | D | Common Stock | 542 | 235.18 | 127.5K | 12,027 | — | ↗ |
| 2023-02-25 | Logue Daniel V. | Officer | F-InKind | D | Common Stock | 40 | 235.18 | 9.4K | 9,452 | — | ↗ |
| 2023-02-25 | Kelly Liam | Director / Officer | F-InKind | D | Common Stock | 1,025 | 235.18 | 241.1K | 19,188 | — | ↗ |
| 2023-02-25 | Hicks Cameron P | Officer | F-InKind | D | Common Stock | 134 | 235.18 | 31.5K | 8,139 | — | ↗ |
| 2023-02-25 | Deren John | Officer | F-InKind | D | Common Stock | 88 | 235.18 | 20.7K | 1,181 | — | ↗ |
| 2023-01-27 | Klasko Stephen K. M.D. | Director | F-InKind | D | Common Stock | 967 | 244.68 | 236.6K | 3,882 | — | ↗ |
| 2023-01-11 | Kelly Liam | Director / Officer | M-Exempt | A | Common Stock | 3,579 | 82.26 | 294.4K | 22,365 | D | ↗ |
| 2022-12-31 | Kelly Liam | Director / Officer | — | I | Common Stock | 0 | 0.00 | — | 13,531 | — | ↗ |
| 2022-12-30 | Kelly Liam | Officer | M-Exempt | A | Common Stock | 16,343 | 78.62 | 1.28M | 32,153 | — | ↗ |
| 2022-06-07 | RANDLE STUART A | Director | S-Sale | D | Common Stock | 3,014 | 283.31 | 853.9K | 4,320 | — | ↗ |
| 2022-05-03 | RANDLE STUART A | Director | A-Award | A | Common Stock | 399 | 0.00 | — | 4,320 | — | ↗ |
| 2022-05-03 | Patil Neena M | Director | A-Award | A | Stock Option / (Right to Buy) | 1,937 | 0.00 | — | 1,937 | — | ↗ |
| 2022-05-03 | Krakauer Andrew A | Director | A-Award | A | Common Stock | 399 | 0.00 | — | 3,936 | — | ↗ |
| 2022-05-03 | Klasko Stephen K. M.D. | Director | A-Award | A | Common Stock | 399 | 0.00 | — | 1,828 | — | ↗ |
| 2022-05-03 | HEINMILLER JOHN C | Director | A-Award | A | Stock Option / (Right to Buy) | 969 | 0.00 | — | 969 | — | ↗ |
| 2022-05-03 | HAGGERTY GRETCHEN R | Director | A-Award | A | Common Stock | 399 | 0.00 | — | 3,578 | — | ↗ |
| 2022-05-03 | Duncan Candace H | Director | A-Award | A | Stock Option / (Right to Buy) | 969 | 0.00 | — | 969 | — | ↗ |
| 2022-05-03 | BABICH GEORGE JR | Director | A-Award | A | Stock Option / (Right to Buy) | 969 | 284.85 | 276.0K | 969 | — | ↗ |
| 2022-04-29 | Patil Neena M | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-03-01 | Winters James | Officer | A-Award | A | Stock Option / (Right to Buy) | 5,208 | 333.24 | 1.74M | 5,208 | — | ↗ |
| 2022-03-01 | White Jay | Officer | A-Award | A | Common Stock | 993 | 0.00 | — | 3,380 | — | ↗ |
| 2022-03-01 | POWELL THOMAS E | Officer | A-Award | A | Stock Option / (Right to Buy) | 14,160 | 333.24 | 4.72M | 14,160 | — | ↗ |
| 2022-03-01 | Logue Daniel V. | Officer | A-Award | A | Stock Option / (Right to Buy) | 4,557 | 333.24 | 1.52M | 4,557 | — | ↗ |
| 2022-03-01 | Kelly Liam | Director / Officer | A-Award | A | Common Stock | 4,766 | 0.00 | — | 29,341 | — | ↗ |
| 2022-03-01 | Hicks Cameron P | Officer | A-Award | A | Common Stock | 600 | 0.00 | — | 8,273 | — | ↗ |
| 2022-03-01 | Deren John | Officer | A-Award | A | Stock Option / (Right to Buy) | 2,441 | 333.24 | 813.4K | 2,441 | — | ↗ |
| 2022-02-28 | Winters James | Officer | F-InKind | D | Common Stock | 223 | 343.01 | 76.5K | 1,018 | — | ↗ |
| 2022-02-28 | White Jay | Officer | F-InKind | D | Common Stock | 132 | 343.01 | 45.3K | 2,387 | — | ↗ |
| 2022-02-28 | POWELL THOMAS E | Officer | F-InKind | D | Common Stock | 728 | 343.01 | 249.7K | 10,841 | — | ↗ |
| 2022-02-28 | Logue Daniel V. | Officer | F-InKind | D | Common Stock | 59 | 343.01 | 20.2K | 8,936 | — | ↗ |
| 2022-02-28 | Kelly Liam | Director / Officer | F-InKind | D | Common Stock | 1,244 | 343.01 | 426.7K | 24,575 | — | ↗ |
| 2022-02-28 | Hicks Cameron P | Officer | F-InKind | D | Common Stock | 171 | 343.01 | 58.7K | 7,673 | — | ↗ |
| 2022-02-28 | Deren John | Officer | F-InKind | D | Common Stock | 121 | 343.01 | 41.5K | 971 | — | ↗ |
| 2021-12-31 | Hicks Cameron P | Officer | — | I | Common Stock | 0 | 0.00 | — | 36 | — | ↗ |
| 2021-12-31 | HEINMILLER JOHN C | Director | — | I | Common Stock | 0 | 0.00 | — | 864 | — | ↗ |
| 2021-12-27 | Kelly Liam | Director / Officer | M-Exempt | A | Common Stock | 6,711 | 59.96 | 402.4K | 34,762 | — | ↗ |
| 2021-11-30 | Krakauer Andrew A | Director | P-Purchase | A | Common Stock | 500 | 307.46 | 153.7K | 3,534 | — | ↗ |
| 2021-11-10 | Hicks Cameron P | Officer | S-Sale | D | Common Stock | 3,600 | 350.00 | 1.26M | 8,604 | — | ↗ |
| 2021-08-24 | Deren John | Officer | A-Award | A | Common Stock | 45 | 0.00 | — | 1,089 | — | ↗ |
| 2021-08-18 | Kelly Liam | Director / Officer | M-Exempt | A | Common Stock | 8,987 | 59.75 | 537.0K | 34,762 | — | ↗ |
| 2021-07-12 | Klasko Stephen K. M.D. | Director | S-Sale | D | Common Stock | 1,200 | 423.39 | 508.1K | 1,574 | — | ↗ |
| 2021-06-10 | Hicks Cameron P | Officer | M-Exempt | A | Common Stock | 1,800 | 121.00 | 217.8K | 12,080 | — | ↗ |
| 2021-06-04 | RANDLE STUART A | Director | S-Sale | D | Common Stock | 2,384 | 395.66 | 943.3K | 4,199 | — | ↗ |
| 2021-05-04 | RANDLE STUART A | Director | A-Award | A | Stock Option / (Right to Buy) | 771 | 412.68 | 318.2K | 771 | — | ↗ |
| 2021-05-04 | PACKER RICHARD A | Director | A-Award | A | Stock Option / (Right to Buy) | 771 | 412.68 | 318.2K | 771 | — | ↗ |
| 2021-05-04 | Krakauer Andrew A | Director | A-Award | A | Stock Option / (Right to Buy) | 771 | 412.68 | 318.2K | 771 | — | ↗ |
| 2021-05-04 | Klasko Stephen K. M.D. | Director | A-Award | A | Stock Option / (Right to Buy) | 771 | 412.68 | 318.2K | 771 | — | ↗ |
| 2021-05-04 | HEINMILLER JOHN C | Director | A-Award | A | Stock Option / (Right to Buy) | 771 | 412.68 | 318.2K | 771 | — | ↗ |
| 2021-05-04 | HAGGERTY GRETCHEN R | Director | A-Award | A | Stock Option / (Right to Buy) | 771 | 412.68 | 318.2K | 771 | — | ↗ |
| 2021-05-04 | Duncan Candace H | Director | A-Award | A | Stock Option / (Right to Buy) | 771 | 412.68 | 318.2K | 771 | — | ↗ |
| 2021-05-04 | BABICH GEORGE JR | Director | A-Award | A | Stock Option / (Right to Buy) | 771 | 412.68 | 318.2K | 771 | — | ↗ |
| 2021-04-23 | Winters James | Officer | F-InKind | D | Common Stock | 107 | 443.71 | 47.5K | 1,241 | — | ↗ |
| 2021-03-15 | Hicks Cameron P | Officer | S-Sale | D | Common Stock | 2,000 | 420.61 | 841.2K | 9,604 | — | ↗ |
| 2021-03-02 | Winters James | Officer | A-Award | A | Common Stock | 385 | 0.00 | — | 1,348 | — | ↗ |
| 2021-03-02 | White Jay | Officer | A-Award | A | Common Stock | 498 | 0.00 | — | 2,515 | — | ↗ |
| 2021-03-02 | POWELL THOMAS E | Officer | A-Award | A | Stock Option / (Right to Buy) | 10,399 | 403.78 | 4.20M | 10,399 | — | ↗ |
| 2021-03-02 | Logue Daniel V. | Officer | A-Award | A | Stock Option / (Right to Buy) | 2,513 | 403.78 | 1.01M | 2,513 | — | ↗ |
| 2021-03-02 | Kelly Liam | Director / Officer | A-Award | A | Common Stock | 3,694 | 0.00 | — | 25,775 | — | ↗ |
| 2021-03-02 | Hicks Cameron P | Officer | A-Award | A | Common Stock | 460 | 0.00 | — | 8,278 | — | ↗ |
| 2021-03-02 | Deren John | Officer | A-Award | A | Common Stock | 225 | 0.00 | — | 1,044 | — | ↗ |
| 2021-02-27 | White Jay | Officer | F-InKind | D | Common Stock | 118 | 398.12 | 47.0K | 2,017 | — | ↗ |
| 2021-02-27 | POWELL THOMAS E | Officer | F-InKind | D | Common Stock | 769 | 398.12 | 306.2K | 10,224 | — | ↗ |
| 2021-02-27 | Logue Daniel V. | Officer | F-InKind | D | Common Stock | 109 | 398.12 | 43.4K | 8,672 | — | ↗ |
| 2021-02-27 | Kelly Liam | Director / Officer | F-InKind | D | Common Stock | 1,282 | 398.12 | 510.4K | 22,081 | — | ↗ |
| 2021-02-27 | Hicks Cameron P | Officer | F-InKind | D | Common Stock | 186 | 398.12 | 74.1K | 7,818 | — | ↗ |
| 2021-02-27 | Deren John | Officer | F-InKind | D | Common Stock | 129 | 398.12 | 51.4K | 819 | — | ↗ |
| 2021-02-23 | White Jay | Officer | — | D | Common Stock | 0 | 0.00 | — | 2,135 | — | ↗ |
| 2021-01-29 | Logue Daniel V. | Officer | — | I | Common Stock | 0 | 0.00 | — | 295 | — | ↗ |
| 2020-12-31 | Leyden James J | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-31 | Hicks Cameron P | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-28 | Leyden James J | Officer | M-Exempt | A | Common Stock | 3,400 | 57.78 | 196.5K | 18,906 | — | ↗ |
| 2020-12-02 | Hicks Cameron P | Officer | M-Exempt | D | Stock Option / (Right to Buy) | 588 | 101.12 | 59.5K | 4,676 | — | ↗ |
| 2020-11-30 | Hicks Cameron P | Officer | M-Exempt | D | Stock Option / (Right to Buy) | 2,985 | 85.54 | 255.3K | 0 | — | ↗ |
| 2020-10-26 | Klasko Stephen K. M.D. | Director | M-Exempt | A | Common Stock | 200 | 58.25 | 11.7K | 1,321 | — | ↗ |
| 2020-09-25 | Klasko Stephen K. M.D. | Director | M-Exempt | A | Common Stock | 200 | 58.25 | 11.7K | 1,321 | — | ↗ |
| 2020-08-25 | Klasko Stephen K. M.D. | Director | M-Exempt | A | Common Stock | 200 | 58.25 | 11.7K | 1,321 | — | ↗ |
| 2020-07-27 | Klasko Stephen K. M.D. | Director | S-Sale | D | Common Stock | 200 | 386.35 | 77.3K | 1,121 | — | ↗ |
| 2020-06-25 | Klasko Stephen K. M.D. | Director | M-Exempt | A | Common Stock | 200 | 58.25 | 11.7K | 1,321 | — | ↗ |
| 2020-05-26 | Klasko Stephen K. M.D. | Director | M-Exempt | A | Common Stock | 200 | 58.25 | 11.7K | 1,321 | — | ↗ |
| 2020-05-11 | Hicks Cameron P | Officer | M-Exempt | D | Stock Option / (Right to Buy) | 400 | 101.12 | 40.4K | 5,264 | — | ↗ |
| 2020-05-09 | Deren John | Officer | F-InKind | D | Common Stock | 38 | 340.30 | 12.9K | 948 | — | ↗ |
| 2020-05-07 | Hicks Cameron P | Officer | M-Exempt | D | Stock Option / (Right to Buy) | 1,400 | 85.54 | 119.8K | 3,492 | — | ↗ |
| 2020-05-05 | RANDLE STUART A | Director | A-Award | A | Stock Option / (Right to Buy) | 1,187 | 340.75 | 404.5K | 1,187 | — | ↗ |
| 2020-05-05 | PACKER RICHARD A | Director | A-Award | A | Stock Option / (Right to Buy) | 1,187 | 340.75 | 404.5K | 1,187 | — | ↗ |
| 2020-05-05 | Krakauer Andrew A | Director | A-Award | A | Stock Option / (Right to Buy) | 1,187 | 340.75 | 404.5K | 1,187 | — | ↗ |
Executive team
Top executives
EBIT / Employee
8.8K
Shares Outstanding
44.27M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Liam J. Kelly Former President and Chief Executive Officer | — | 143.1K | 2.01M | 2.89M | 227.3K | 325.6K | 5.59M | 87.55% | ↗ |
| 2 | 2025 | John R. Deren Executive Vice President and Chief Financial Officer | 548.9K | 144.6K | 526.4K | 757.7K | 60.0K | 71.1K | 2.11M | 60.81% | ↗ |
| 3 | 2025 | Jay K. White Former Corporate Vice President and President, Global Commercial | 324.6K | 20.5K | 373.0K | 536.8K | 36.1K | 696.9K | 1.99M | 45.75% | ↗ |
| 4 | 2025 | James P. Winters Corporate Vice President, Manufacturing and Supply Chain | 529.0K | 137.0K | 373.0K | 536.8K | 58.8K | 87.7K | 1.72M | 52.82% | ↗ |
| 5 | 2025 | Daniel V. Logue Corporate Vice President, General Counsel and Secretary | 453.4K | 131.7K | 373.0K | 536.8K | 50.4K | 59.4K | 1.60M | 56.69% | ↗ |
| 6 | 2025 | Thomas E. Powell Former Executive Vice President and Chief Financial Officer | 171.9K | — | 278.6K | 526.0K | — | 437.8K | 1.42M | 56.83% | ↗ |
| 7 | 2025 | Cameron P. Hicks Corporate Vice President and Chief Human Resources Officer | 436.3K | 110.5K | 279.7K | 402.6K | 48.5K | 68.7K | 1.35M | 50.68% | ↗ |
| 8 | 2024 | Liam J. Kelly Chairman, President and Chief Executive Officer | 1.11M | 138.4K | 2.74M | 3.41M | 1.45M | 358.2K | 9.20M | 66.88% | ↗ |
| 9 | 2024 | Liam J. Kelly Former President and Chief Executive Officer | 1.11M | 138.4K | 2.74M | 3.41M | 1.45M | 358.2K | 9.20M | 66.88% | ↗ |
| 10 | 2024 | Thomas E. Powell Former Executive Vice President and Chief Financial Officer | 659.5K | 49.5K | 959.7K | 1.19M | 516.6K | 181.9K | 3.56M | 60.47% | ↗ |
| 11 | 2024 | Thomas E. Powell Executive Vice President and Chief Financial Officer | 659.5K | 49.5K | 959.7K | 1.19M | 516.6K | 181.9K | 3.56M | 60.47% | ↗ |
| 12 | 2024 | Jay K. White Corporate Vice President and President, Global Commercial | 626.8K | 39.5K | 548.5K | 681.8K | 458.3K | 82.3K | 2.44M | 50.48% | ↗ |
| 13 | 2024 | Jay K. White Former Corporate Vice President and President, Global Commercial | 626.8K | 39.5K | 548.5K | 681.8K | 458.3K | 82.3K | 2.44M | 50.48% | ↗ |
| 14 | 2024 | James P. Winters Corporate Vice President, Manufacturing and Supply Chain | 428.2K | 33.6K | 537.3K | 666.3K | 313.1K | 72.1K | 2.05M | 58.70% | ↗ |
| 15 | 2024 | Daniel V. Logue Corporate Vice President, General Counsel and Secretary | 435.7K | 30.5K | 532.6K | 661.9K | 318.6K | 57.2K | 2.04M | 58.66% | ↗ |
| 16 | 2023 | Liam J. Kelly Chairman, President and Chief Executive Officer | 1.06M | 132.5K | 2.84M | 3.58M | 1.13M | 308.0K | 9.04M | 70.92% | ↗ |
| 17 | 2023 | Liam J. Kelly Former President and Chief Executive Officer | 1.06M | 132.5K | 2.84M | 3.58M | 1.13M | 308.0K | 9.04M | 70.92% | ↗ |
| 18 | 2023 | Thomas E. Powell Former Executive Vice President and Chief Financial Officer | 631.2K | 56.8K | 992.6K | 1.25M | 403.0K | 197.0K | 3.53M | 63.51% | ↗ |
| 19 | 2023 | Thomas E. Powell Executive Vice President and Chief Financial Officer | 631.2K | 56.8K | 992.6K | 1.25M | 403.0K | 197.0K | 3.53M | 63.51% | ↗ |
| 20 | 2023 | Jay K. White Former Corporate Vice President and President, Global Commercial | 607.3K | 42.5K | 567.1K | 715.2K | 361.9K | 77.4K | 2.37M | 54.07% | ↗ |
| 21 | 2023 | Jay K. White Corporate Vice President and President, Global Commercial | 607.3K | 42.5K | 567.1K | 715.2K | 361.9K | 77.4K | 2.37M | 54.07% | ↗ |
| 22 | 2023 | Daniel V. Logue Corporate Vice President, General Counsel and Secretary | 403.1K | 28.2K | 479.8K | 605.2K | 240.2K | 48.7K | 1.81M | 60.10% | ↗ |
| 23 | 2023 | James P. Winters Corporate Vice President, Manufacturing and Supply Chain | 404.4K | 34.0K | 383.9K | 484.1K | 241.0K | 70.1K | 1.62M | 53.67% | ↗ |
| 24 | 2022 | Liam J. Kelly Chairman, President and Chief Executive Officer | 1.02M | 127.9K | 2.68M | 3.50M | 539.8K | 313.7K | 8.19M | 75.53% | ↗ |
| 25 | 2022 | Thomas E. Powell Executive Vice President and Chief Financial Officer | 609.1K | 45.7K | 972.9K | 1.27M | 192.8K | 190.2K | 3.28M | 68.35% | ↗ |
| 26 | 2022 | Jay K. White Corporate Vice President and President, Global Commercial | 584.6K | 36.8K | 559.0K | 729.7K | 172.7K | 72.7K | 2.16M | 59.78% | ↗ |
| 27 | 2022 | James P. Winters Corporate Vice President, Manufacturing and Supply Chain | 371.6K | 28.6K | 357.5K | 467.0K | 119.5K | 64.9K | 1.41M | 58.51% | ↗ |
| 28 | 2022 | Cameron P. Hicks Corporate Vice President and Chief Human Resources Officer | 388.1K | 23.3K | 337.8K | 440.7K | 98.3K | 55.0K | 1.34M | 57.96% | ↗ |
| 29 | 2021 | Liam J. Kelly Chairman, President and Chief Executive Officer | 981.5K | 122.7K | 2.66M | 3.00M | 1.68M | 220.3K | 8.67M | 65.31% | ↗ |
| 30 | 2021 | Thomas E. Powell Executive Vice President and Chief Financial Officer | 591.4K | 62.1K | 958.4K | 1.08M | 608.9K | 174.5K | 3.48M | 58.64% | ↗ |
| 31 | 2021 | Jay K. White Corporate Vice President and President, Global Commercial | 562.7K | 55.1K | 359.2K | 404.5K | 540.7K | 72.0K | 1.99M | 38.29% | ↗ |
| 32 | 2021 | Cameron P. Hicks Corporate Vice President and Chief Human Resources Officer | 371.4K | 30.1K | 331.9K | 373.6K | 305.9K | 64.1K | 1.48M | 47.77% | ↗ |
| 33 | 2021 | James P. Winters Corporate Vice President, Manufacturing and Supply Chain | 370.1K | 32.2K | 278.0K | 313.1K | 289.7K | 66.4K | 1.35M | 43.80% | ↗ |
| 34 | 2020 | Liam J. Kelly Chairman, President and Chief Executive Officer | 943.4K | 650.9K | 1.98M | 2.34M | 217.0K | 197.8K | 6.33M | 68.25% | ↗ |
| 35 | 2020 | Thomas E. Powell Executive Vice President and Chief Financial Officer | 594.3K | 267.4K | 818.2K | 970.5K | 89.1K | 128.5K | 2.88M | 62.17% | ↗ |
| 36 | 2020 | James J. Leyden Corporate Vice President, General Counsel and Secretary | 387.2K | 116.1K | 377.4K | 447.9K | 38.7K | 48.9K | 1.42M | 58.28% | ↗ |
| 37 | 2020 | Cameron P. Hicks Corporate Vice President and Chief Human Resources Officer | 354.5K | 106.4K | 251.7K | 298.6K | 35.5K | 47.5K | 1.09M | 50.30% | ↗ |
| 38 | 2020 | James P. Winters Corporate Vice President, Manufacturing and Supply Chain | 368.0K | 26.6K | 203.5K | 241.5K | 120.5K | 64.7K | 1.02M | 43.42% | ↗ |
| 39 | 2019 | Liam J. Kelly President and Chief Executive Officer | 868.6K | — | 2.05M | 2.41M | 1.20M | 262.6K | 6.78M | 65.67% | ↗ |
| 40 | 2019 | Liam J. Kelly Chairman, President and Chief Executive Officer | 868.6K | — | 2.05M | 2.41M | 1.20M | 262.6K | 6.78M | 65.67% | ↗ |
| 41 | 2019 | Thomas E. Powell Executive Vice President and Chief Financial Officer | 551.5K | — | 962.0K | 1.13M | 495.6K | 157.9K | 3.30M | 63.38% | ↗ |
| 42 | 2019 | James J. Leyden Corporate Vice President, General Counsel and Secretary | 362.6K | — | 444.2K | 522.0K | 194.4K | 55.3K | 1.58M | 61.21% | ↗ |
| 43 | 2019 | Cameron P. Hicks Corporate Vice President, Human Resources and Communications | 329.0K | — | 295.9K | 348.0K | 177.4K | 51.5K | 1.20M | 53.58% | ↗ |
| 44 | 2019 | Cameron P. Hicks Corporate Vice President and Chief Human Resources Officer | 329.0K | — | 295.9K | 384.0K | 177.4K | 51.5K | 1.20M | 56.58% | ↗ |
| 45 | 2019 | Karen T. Boylan Corporate Vice President, Strategic Projects | 288.6K | — | 160.3K | 188.5K | 154.3K | 55.9K | 847.6K | 41.15% | ↗ |
| 46 | 2018 | Liam J. Kelly President and Chief Executive Officer | 845.7K | — | 1.80M | 2.01M | 1.20M | 244.1K | 6.11M | 62.48% | ↗ |
| 47 | 2018 | Liam J. Kelly Chairman, President and Chief Executive Officer | 845.7K | — | 1.80M | 2.01M | 1.20M | 244.1K | 6.11M | 62.48% | ↗ |
| 48 | 2018 | Thomas E. Powell Executive Vice President and Chief Financial Officer | 535.4K | — | 814.8K | 908.9K | 500.3K | 128.2K | 2.89M | 59.70% | ↗ |
| 49 | 2018 | James J. Leyden Corporate Vice President, General Counsel and Secretary | 347.7K | — | 414.3K | 462.2K | 193.4K | 35.3K | 1.45M | 60.33% | ↗ |
| 50 | 2018 | James J. Leyden Vice President, General Counsel and Secretary | 347.7K | — | 414.3K | 462.2K | 193.4K | 35.3K | 1.45M | 60.33% | ↗ |
| 51 | 2018 | Cameron P. Hicks Vice President, Global Human Resources and Employee Communications | 317.8K | — | 278.8K | 311.0K | 176.8K | 44.7K | 1.13M | 52.24% | ↗ |
| 52 | 2018 | Cameron P. Hicks Corporate Vice President, Human Resources and Communications | 317.8K | — | 278.8K | 311.0K | 176.8K | 44.7K | 1.13M | 52.24% | ↗ |
| 53 | 2018 | Cameron P. Hicks Corporate Vice President and Chief Human Resources Officer | 317.8K | — | 278.8K | 311.0K | 176.8K | 44.7K | 1.13M | 52.24% | ↗ |
| 54 | 2018 | Thomas Anthony Kennedy Senior Vice President, Global Operations | 329.4K | — | 164.4K | 321.4K | 102.9K | 67.6K | 985.6K | 49.28% | ↗ |
| 55 | 2018 | Karen T. Boylan Corporate Vice President, Strategic Projects | 257.7K | — | 127.8K | 142.8K | 143.3K | 59.3K | 730.9K | 37.03% | ↗ |
| 56 | 2018 | Karen T. Boylan Vice President, Global Strategic Projects | 257.7K | — | 127.8K | 142.8K | 143.3K | 59.3K | 730.9K | 37.03% | ↗ |
| 57 | 2017 | Benson F. Smith Chairman and Former Chief Executive Officer | 939.7K | — | 1.46M | 2.67M | 2.98M | 288.5K | 8.34M | 49.54% | ↗ |
| 58 | 2017 | Liam J. Kelly President and Chief Executive Officer | 616.8K | — | 630.1K | 1.16M | 693.0K | 204.0K | 3.30M | 54.13% | ↗ |
| 59 | 2017 | Thomas E. Powell Executive Vice President and Chief Financial Officer | 520.5K | — | 472.4K | 867.2K | 548.2K | 109.2K | 2.52M | 53.22% | ↗ |
| 60 | 2017 | James J. Leyden Corporate Vice President, General Counsel and Secretary | 321.9K | — | 259.1K | 475.5K | 235.3K | 41.6K | 1.33M | 55.09% | ↗ |
| 61 | 2017 | James J. Leyden Vice President, General Counsel and Secretary | 321.9K | — | 259.1K | 475.5K | 235.3K | 41.6K | 1.33M | 55.09% | ↗ |
| 62 | 2017 | Thomas Anthony Kennedy Senior Vice President, Global Operations | 339.2K | — | 194.9K | 357.7K | 140.5K | 46.1K | 1.08M | 51.24% | ↗ |
| 63 | 2017 | Cameron P. Hicks Vice President, Global Human Resources and Employee Communications | 304.6K | — | 174.1K | 319.4K | 171.1K | 47.0K | 1.08M | 45.76% | ↗ |
| 64 | 2017 | Cameron P. Hicks Corporate Vice President, Human Resources and Communications | 304.6K | — | 174.1K | 319.4K | 171.1K | 47.0K | 1.08M | 45.76% | ↗ |
| 65 | 2016 | Benson F. Smith Chairman and Former Chief Executive Officer | 916.8K | — | 1.12M | 2.11M | 1.62M | 290.1K | 6.05M | 53.34% | ↗ |
| 66 | 2016 | Benson F. Smith Chairman and Chief Executive Officer | 916.8K | — | 1.12M | 2.11M | 1.62M | 290.1K | 6.05M | 53.34% | ↗ |
| 67 | 2016 | Liam J. Kelly President and Chief Operating Officer | 580.5K | — | 531.8K | 1.00M | 534.8K | 146.3K | 2.80M | 54.88% | ↗ |
| 68 | 2016 | Liam J. Kelly President and Chief Executive Officer | 580.5K | — | 531.8K | 1.00M | 534.8K | 146.3K | 2.80M | 54.88% | ↗ |
| 69 | 2016 | Thomas E. Powell Executive Vice President and Chief Financial Officer | 504.6K | — | 459.1K | 866.9K | 444.7K | 112.4K | 2.39M | 55.53% | ↗ |
| 70 | 2016 | James J. Leyden Vice President, General Counsel and Secretary | 301.4K | — | 231.8K | 437.8K | 141.6K | 33.6K | 1.15M | 58.42% | ↗ |
| 71 | 2016 | Cameron P. Hicks Vice President, Global Human Resources | 297.1K | — | 158.3K | 299.1K | 139.7K | 39.2K | 933.4K | 49.00% | ↗ |
| 72 | 2016 | Cameron P. Hicks Vice President, Global Human Resources and Employee Communications | 297.1K | — | 158.3K | 299.1K | 139.7K | 39.2K | 933.4K | 49.00% | ↗ |
| 73 | 2016 | Thomas Anthony Kennedy Senior Vice President, Global Operations | 280.9K | — | 163.8K | 309.2K | 137.0K | 39.1K | 930.0K | 50.86% | ↗ |
| 74 | 2015 | Benson F. Smith Chairman, President and Chief Executive Officer | 895.7K | — | 860.5K | 1.61M | 1.65M | 411.5K | 5.43M | 45.56% | ↗ |
| 75 | 2015 | Benson F. Smith Chairman and Former Chief Executive Officer | 895.7K | — | 860.5K | 1.61M | 1.65M | 411.5K | 5.43M | 45.56% | ↗ |
| 76 | 2015 | Benson F. Smith Chairman and Chief Executive Officer | 895.7K | — | 860.5K | 1.61M | 1.65M | 411.5K | 5.43M | 45.56% | ↗ |
| 77 | 2015 | Liam J. Kelly President and Chief Operating Officer | 532.1K | — | 418.5K | 783.7K | 473.5K | 373.7K | 2.58M | 46.57% | ↗ |
| 78 | 2015 | Liam J. Kelly President and Chief Executive Officer | 532.1K | — | 418.5K | 783.7K | 473.5K | 373.7K | 2.58M | 46.57% | ↗ |
| 79 | 2015 | Liam J. Kelly Executive Vice President and Chief Operating Officer | 532.1K | — | 418.5K | 783.7K | 473.5K | 373.7K | 2.58M | 46.57% | ↗ |
| 80 | 2015 | Thomas E. Powell Executive Vice President and Chief Financial Officer | 484.2K | — | 406.1K | 760.7K | 415.6K | 119.7K | 2.19M | 53.37% | ↗ |
| 81 | 2015 | James J. Leyden Vice President, General Counsel and Secretary | 288.0K | — | 141.1K | 264.2K | 141.2K | 25.1K | 859.6K | 47.15% | ↗ |
| 82 | 2015 | T. Anthony Kennedy Senior Vice President, Global Operations | 286.8K | — | 117.8K | 220.6K | 137.3K | 40.3K | 802.7K | 42.15% | ↗ |
| 83 | 2015 | Thomas Anthony Kennedy Senior Vice President, Global Operations | 286.8K | — | 117.8K | 220.6K | 137.3K | 40.3K | 802.7K | 42.15% | ↗ |
| 84 | 2015 | Cameron P. Hicks Vice President, Global Human Resources | 290.3K | — | 105.5K | 197.6K | 142.4K | 23.8K | 759.6K | 39.91% | ↗ |
| 85 | 2014 | Benson F. Smith Chairman and Chief Executive Officer | 866.7K | — | 819.3K | 1.48M | 2.03M | 342.2K | 5.54M | 41.52% | ↗ |
| 86 | 2014 | Benson F. Smith Chairman, President and Chief Executive Officer | 866.7K | — | 819.3K | 1.48M | 2.03M | 342.2K | 5.54M | 41.52% | ↗ |
| 87 | 2014 | Liam J. Kelly President and Chief Operating Officer | 431.5K | — | 262.8K | 474.8K | 488.2K | 540.8K | 2.20M | 33.56% | ↗ |
| 88 | 2014 | Liam J. Kelly Executive Vice President and Chief Operating Officer | 431.5K | — | 262.8K | 474.8K | 488.2K | 540.8K | 2.20M | 33.56% | ↗ |
| 89 | 2014 | Thomas E. Powell Executive Vice President and Chief Financial Officer | 468.6K | — | 301.2K | 544.4K | 512.6K | 93.0K | 1.92M | 44.05% | ↗ |
| 90 | 2014 | T. Anthony Kennedy Senior Vice President, Global Operations | 312.2K | — | 70.1K | 126.7K | 167.3K | 44.4K | 720.7K | 27.31% | ↗ |
| 91 | 2014 | Liam Kelly Executive Vice President and President – International Thomas Anthony Kennedy Senior Vice President, Global Operations Cameron P. Hicks Vice President, Global Human Resources | 312.2K | — | 70.1K | 126.7K | 167.3K | 44.4K | 720.7K | 27.31% | ↗ |
| 92 | 2014 | Cameron P. Hicks Vice President, Global Human Resources | 281.8K | — | 56.2K | 101.7K | 176.1K | 23.4K | 639.2K | 24.70% | ↗ |
| 93 | 2013 | Benson F. Smith Chairman, President and Chief Executive Officer | 826.6K | — | 761.5K | 1.34M | 1.42M | 261.4K | 4.60M | 45.57% | ↗ |
| 94 | 2013 | Thomas E. Powell Executive Vice President and Chief Financial Officer | 441.5K | — | 280.0K | 491.2K | 343.8K | 240.9K | 1.80M | 42.91% | ↗ |
| 95 | 2013 | Laurence G. Miller Former Exec. Vice President, Chief Admin Officer, General Counsel and Secretary | 462.5K | — | 291.2K | 510.8K | 356.9K | 87.9K | 1.71M | 46.92% | ↗ |
| 96 | 2013 | Liam J. Kelly Executive Vice President and Chief Operating Officer | 427.1K | — | 211.1K | 370.0K | 280.3K | 83.1K | 1.37M | 42.37% | ↗ |
| 97 | 2013 | Liam Kelly Executive Vice President and President – International | 427.1K | — | 211.1K | 370.0K | 280.3K | 83.1K | 1.37M | 42.37% | ↗ |
| 98 | 2012 | Benson F. Smith Chairman, President and Chief Executive Officer | 800.0K | — | 698.6K | 1.30M | 2.60M | 363.4K | 5.76M | 34.68% | ↗ |
| 99 | 2012 | Laurence G. Miller Former Exec. Vice President, Chief Admin Officer, General Counsel and Secretary | 450.0K | — | 267.2K | 497.0K | 413.4K | 83.8K | 1.72M | 44.41% | ↗ |
| 100 | 2012 | Laurence G. Miller Executive Vice President, Chief Admin Officer, General Counsel and Secretary | 450.0K | — | 267.2K | 497.0K | 413.4K | 83.8K | 1.72M | 44.41% | ↗ |
| 101 | 2012 | Richard A. Meier Former Executive Vice President and Chief Financial Officer | 140.0K | — | 363.3K | 675.6K | — | 468.3K | 1.65M | 63.07% | ↗ |
| 102 | 2012 | Liam Kelly Executive Vice President and President – International | 355.4K | — | 113.8K | 211.7K | 260.1K | 72.2K | 1.01M | 32.12% | ↗ |
| 103 | 2012 | Thomas E. Powell Executive Vice President and Chief Financial Officer | 380.2K | — | 93.1K | 173.1K | 262.8K | 57.6K | 966.7K | 27.53% | ↗ |
| 104 | 2011 | Benson F. Smith Chairman, President and Chief Executive Officer | 738.5K | 100.0K | 670.5K | 1.24M | 1.04M | 293.0K | 4.09M | 46.78% | ↗ |
| 105 | 2011 | Richard A. Meier Former Executive Vice President and Chief Financial Officer | 516.9K | — | 348.7K | 645.7K | 260.5K | 202.0K | 1.97M | 50.38% | ↗ |
| 106 | 2011 | Laurence G. Miller Executive Vice President, Chief Admin Officer, General Counsel and Secretary Jeffrey P. Black Former Chairman, President and Chief Executive Officer | 114.2K | — | — | — | — | 1.75M | 1.97M | 0.00% | ↗ |
| 107 | 2011 | Laurence G. Miller Executive Vice President, Chief Admin Officer, General Counsel and Secretary | 431.3K | — | 384.7K | 477.2K | 274.1K | 79.5K | 1.68M | 51.37% | ↗ |
| 108 | 2011 | Benson F. Smith Chairman, President and Chief Executive Officer Laurence G. Miller Executive Vice President, Chief Admin Officer, General Counsel and Secretary | 431.3K | — | 384.7K | 477.2K | 274.1K | 79.5K | 1.68M | 51.37% | ↗ |
| 109 | 2011 | Laurence G. Miller Former Exec. Vice President, Chief Admin Officer, General Counsel and Secretary | 431.3K | — | 384.7K | 477.2K | 274.1K | 79.5K | 1.68M | 51.37% | ↗ |
| 110 | 2011 | Jeffrey P. Black Former Chairman, President and Chief Executive Officer John B. Suddarth Former President – Commercial, Aerospace and Medical OEM | 103.8K | — | 169.6K | 314.1K | — | 258.1K | 880.5K | 54.94% | ↗ |
| 111 | 2011 | Liam Kelly Executive Vice President and President – International | 308.1K | — | 215.1K | — | 124.2K | 32.6K | 679.9K | 31.63% | ↗ |
| 112 | 2011 | Thomas E. Powell Executive Vice President and Chief Financial Officer | 115.1K | 100.0K | 86.9K | 155.4K | 45.1K | 22.2K | 524.7K | 46.18% | ↗ |
| 113 | 2010 | Jeffrey P. Black Former Chairman, President and Chief Executive Officer | 900.0K | — | 1.02M | — | 567.0K | 167.4K | 4.82M | 21.18% | ↗ |
| 114 | 2010 | Laurence G. Miller Executive Vice President, Chief Admin Officer, General Counsel and Secretary Jeffrey P. Black Former Chairman, President and Chief Executive Officer | 900.0K | — | 1.02M | 2.13M | 567.0K | 167.4K | 4.82M | 65.32% | ↗ |
| 115 | 2010 | Richard A. Meier Former Executive Vice President and Chief Financial Officer | 500.0K | 120.0K | 574.3K | 1.19M | 252.0K | 243.1K | 2.88M | 61.33% | ↗ |
| 116 | 2010 | Richard A. Meier Executive Vice President and Chief Financial Officer | 500.0K | 120.0K | 574.3K | — | 252.0K | 243.1K | 2.88M | 19.91% | ↗ |
| 117 | 2010 | R. Ernest Waaser Former President – Medical | 324.0K | 38.9K | 312.0K | — | 84.6K | 211.2K | 1.62M | 19.25% | ↗ |
| 118 | 2010 | Benson F. Smith Chairman, President and Chief Executive Officer Laurence G. Miller Executive Vice President, Chief Admin Officer, General Counsel and Secretary | 387.4K | 93.0K | 219.8K | 458.0K | 146.4K | 68.2K | 1.39M | 48.91% | ↗ |
| 119 | 2010 | Laurence G. Miller Executive Vice President, General Counsel and Secretary | 387.4K | 93.0K | 219.8K | — | 146.4K | 68.2K | 1.39M | 15.86% | ↗ |
| 120 | 2010 | Laurence G. Miller Executive Vice President, Chief Admin Officer, General Counsel and Secretary | 387.4K | 93.0K | 219.8K | 458.0K | 146.4K | 68.2K | 1.39M | 48.91% | ↗ |
| 121 | 2010 | John B. Suddarth President – Commercial, Aerospace and Medical OEM | 337.3K | 42.2K | 191.4K | — | 244.7K | 31.7K | 1.26M | 15.20% | ↗ |
| 122 | 2010 | Jeffrey P. Black Former Chairman, President and Chief Executive Officer John B. Suddarth Former President – Commercial, Aerospace and Medical OEM | 337.3K | 42.2K | 191.4K | 398.8K | 244.7K | 31.7K | 1.26M | 46.86% | ↗ |
| 123 | 2010 | Vince Northfield Executive Vice President – Medical | 387.4K | — | 219.8K | — | 83.8K | 71.9K | 1.24M | 17.71% | ↗ |
| 124 | 2010 | Liam Kelly Executive Vice President and President – International | 304.2K | — | 171.0K | — | 106.8K | 32.0K | 614.0K | 27.85% | ↗ |
| 125 | 2010 | Kevin K. Gordon Former Executive Vice President and Chief Financial Officer | 19.4K | — | — | — | — | 2.1K | 51.5K | 0.00% | ↗ |
| 126 | 2009 | Jeffrey P. Black Chairman, President and Chief Executive Officer | — | — | — | — | — | — | 5.00M | 0.00% | ↗ |
| 127 | 2009 | Laurence G. Miller Executive Vice President, Chief Admin Officer, General Counsel and Secretary Jeffrey P. Black Former Chairman, President and Chief Executive Officer | 900.0K | 180.0K | 845.0K | 1.51M | 1.28M | 272.9K | 5.00M | 46.99% | ↗ |
| 128 | 2009 | Jeffrey P. Black Former Chairman, President and Chief Executive Officer | 900.0K | 180.0K | 845.0K | — | 1.28M | 272.9K | 5.00M | 16.89% | ↗ |
| 129 | 2009 | Kevin K. Gordon Former Executive Vice President and Chief Financial Officer | 427.5K | 77.0K | 259.2K | — | 455.3K | 98.2K | 1.79M | 14.44% | ↗ |
| 130 | 2009 | Kevin K. Gordon Executive Vice President and Chief Financial Officer | — | — | — | — | — | — | 1.79M | 0.00% | ↗ |
| 131 | 2009 | R. Ernest Waaser President – Medical | — | — | — | — | — | — | 1.34M | 0.00% | ↗ |
| 132 | 2009 | R. Ernest Waaser Former President – Medical | 457.5K | 122.8K | 249.4K | — | — | 61.5K | 1.34M | 18.67% | ↗ |
| 133 | 2009 | Laurence G. Miller Executive Vice President, General Counsel and Secretary | 372.5K | 58.1K | 176.6K | — | 317.4K | 77.1K | 1.32M | 13.34% | ↗ |
| 134 | 2009 | Benson F. Smith Chairman, President and Chief Executive Officer Laurence G. Miller Executive Vice President, Chief Admin Officer, General Counsel and Secretary | 372.5K | 58.1K | 176.6K | 314.6K | 317.4K | 77.1K | 1.32M | 37.12% | ↗ |
| 135 | 2009 | Vince Northfield Executive Vice President – Medical | 372.5K | 91.8K | 176.6K | — | — | 73.9K | 1.04M | 16.99% | ↗ |
| 136 | 2009 | Jeffrey P. Black Former Chairman, President and Chief Executive Officer John B. Suddarth Former President – Commercial, Aerospace and Medical OEM | 327.5K | 90.0K | 153.8K | 273.9K | — | 13.3K | 865.3K | 49.43% | ↗ |
| 137 | 2009 | John B. Suddarth President – Commercial, Aerospace and Medical OEM | 327.5K | 90.0K | 153.8K | — | — | 13.3K | 865.3K | 17.77% | ↗ |
| 138 | 2008 | Jeffrey P. Black Former Chairman, President and Chief Executive Officer | 900.0K | 180.0K | 872.4K | — | 1.61M | 118.5K | 5.41M | 16.12% | ↗ |
| 139 | 2008 | Jeffrey P. Black Chairman, President and Chief Executive Officer | — | — | — | — | — | — | 5.41M | 0.00% | ↗ |
| 140 | 2008 | Kevin K. Gordon Former Executive Vice President and Chief Financial Officer | 427.5K | 153.5K | 262.4K | — | 416.4K | 33.8K | 1.80M | 14.55% | ↗ |
| 141 | 2008 | Kevin K. Gordon Executive Vice President and Chief Financial Officer | — | — | — | — | — | — | 1.80M | 0.00% | ↗ |
| 142 | 2008 | Vince Northfield Executive Vice President – Medical | 372.5K | 119.2K | 497.2K | — | 130.4K | 45.4K | 1.52M | 32.69% | ↗ |
| 143 | 2008 | R. Ernest Waaser President – Medical | — | — | — | — | — | — | 1.33M | 0.00% | ↗ |
| 144 | 2008 | R. Ernest Waaser Former President – Medical | 467.5K | 28.1K | 264.3K | — | 84.2K | 30.9K | 1.33M | 19.93% | ↗ |
| 145 | 2008 | Laurence G. Miller Executive Vice President, General Counsel and Secretary | 372.5K | 44.7K | 180.6K | — | 309.1K | 37.8K | 1.32M | 13.73% | ↗ |
| 146 | 2008 | John B. Suddarth President – Commercial, Aerospace and Medical OEM | 327.5K | 52.4K | 158.7K | — | 187.7K | 8.4K | 1.05M | 15.15% | ↗ |
| 147 | 2007 | Jeffrey P. Black Chairman, President and Chief Executive Officer | — | — | — | — | — | — | 3.78M | 0.00% | ↗ |
| 148 | 2007 | Kevin K. Gordon Executive Vice President and Chief Financial Officer | — | — | — | — | — | — | 1.84M | 0.00% | ↗ |
| 149 | 2007 | R. Ernest Waaser President – Medical | 420.0K | — | — | — | — | — | 1.23M | 0.00% | ↗ |
| 150 | 2007 | Laurence G. Miller Executive Vice President, General Counsel and Secretary | — | — | — | — | — | — | 1.05M | 0.00% | ↗ |
| 151 | 2007 | John J. Sickler Vice Chairman | 366.7K | 400.0K | — | — | — | 123.8K | 962.9K | 0.00% | ↗ |
| 152 | 2007 | Vince Northfield Executive Vice President – Medical | — | — | — | — | — | — | 902.7K | 0.00% | ↗ |
| 153 | 2007 | Vince Northfield President – Commercial | 346.5K | 267.4K | — | — | — | 57.1K | 874.6K | 0.00% | ↗ |
| 154 | 2006 | Jeffrey P. Black Chairman, President and Chief Executive Officer | 850.0K | — | — | — | — | — | 3.31M | 0.00% | ↗ |
| 155 | 2006 | John J. Sickler Vice Chairman | 440.0K | 200.0K | 10.7K | — | — | 49.6K | 960.4K | 1.11% | ↗ |
| 156 | 2006 | Martin S. Headley Executive Vice President and Chief Financial Officer | 418.2K | 112.9K | 97.6K | — | — | 33.6K | 948.2K | 10.29% | ↗ |
| 157 | 2006 | Laurence G. Miller Executive Vice President, General Counsel and Secretary | 329.6K | — | — | — | — | — | 732.2K | 0.00% | ↗ |
| 158 | 2006 | John B. Suddarth President — Aerospace | 300.0K | 222.6K | — | — | — | 7.7K | 672.7K | 0.00% | ↗ |
| 159 | 2006 | Vince Northfield President – Commercial | 330.0K | 116.5K | — | — | — | 51.8K | 660.4K | 0.00% | ↗ |
| 160 | 2006 | Vince Northfield Executive Vice President – Medical | 330.0K | — | — | — | — | — | 660.4K | 0.00% | ↗ |
| 161 | 2006 | Vince Northfield President — Commercial | 330.0K | 116.5K | — | — | — | 51.8K | 636.2K | 0.00% | ↗ |
| 162 | 2006 | Kevin K. Gordon Executive Vice President and Chief Financial Officer | 278.1K | — | — | — | — | — | 608.2K | 0.00% | ↗ |
| 163 | 2006 | R. Ernest Waaser President – Medical | 72.7K | 50.0K | 25.1K | — | — | 2.0K | 171.5K | 14.65% | ↗ |
| 164 | 2005 | Jeffrey P. Black Chairman, President and Chief Executive Officer | 750.0K | 877.5K | — | — | — | 19.2K | 1.65M | 0.00% | ↗ |
| 165 | 2005 | John J. Sickler Vice Chairman | 440.0K | 343.2K | — | — | — | 49.1K | 832.3K | 0.00% | ↗ |
| 166 | 2005 | Martin S. Headley(f) | 406.0K | 316.7K | — | — | — | 87.6K | 810.2K | 0.00% | ↗ |
| 167 | 2005 | Lennox K. Black Chairman and Director | 703.0K | — | — | — | — | — | 703.0K | 0.00% | ↗ |
| 168 | 2005 | John B. Suddarth(g) | 298.7K | 270.3K | — | — | — | 6.0K | 575.0K | 0.00% | ↗ |
| 169 | 2004 | Jeffrey P. Black President, Chief Executive Officer | 671.7K | 250.0K | — | — | — | — | 921.7K | 0.00% | ↗ |
| 170 | 2004 | Lennox K. Black Chairman and Director | 703.0K | — | — | — | — | — | 703.0K | 0.00% | ↗ |
| 171 | 2004 | John J. Sickler Vice Chairman | 429.7K | 200.0K | — | — | — | — | 629.7K | 0.00% | ↗ |
| 172 | 2004 | Martin S. Headley | 150.0K | 203.0K | — | — | — | — | 353.0K | 0.00% | ↗ |
| 173 | 2004 | Clark D. Handy | 247.0K | 75.0K | — | — | — | — | 322.0K | 0.00% | ↗ |
| 174 | 2004 | Steven K. Chance Vice President, General Counsel | 288.5K | — | — | — | — | — | 288.5K | 0.00% | ↗ |
| 175 | 2003 | Jeffrey P. Black President, Chief Executive Officer | 530.0K | 190.0K | — | — | — | 7.1K | 727.1K | 0.00% | ↗ |
| 176 | 2003 | Lennox K. Black Chairman and Director | 703.0K | — | — | — | — | 6.2K | 709.2K | 0.00% | ↗ |
| 177 | 2003 | John J. Sickler Vice Chairman | 378.0K | 300.0K | — | — | — | 7.3K | 685.3K | 0.00% | ↗ |
| 178 | 2003 | Harold L. Zuber, Jr. Executive Vice President and Chief | 371.0K | — | — | — | — | 8.1K | 379.1K | 0.00% | ↗ |
| 179 | 2003 | Steven K. Chance Vice President, General Counsel | 288.5K | 75.0K | — | — | — | 9.9K | 373.4K | 0.00% | ↗ |
| 180 | 2002 | Lennox K. Black Chairman and Director | 790.7K | — | — | — | — | 73.5K | 864.2K | 0.00% | ↗ |
| 181 | 2002 | Lennox K. Black Chairman, Chief Executive Officer | 790.7K | — | — | — | — | 73.5K | 864.2K | 0.00% | ↗ |
| 182 | 2002 | Jeffrey P. Black President, Chief Executive Officer | 476.7K | 250.0K | — | — | — | 6.4K | 733.1K | 0.00% | ↗ |
| 183 | 2002 | Harold L. Zuber, Jr. Executive Vice President and Chief | 351.0K | 200.0K | — | — | — | 7.6K | 558.6K | 0.00% | ↗ |
| 184 | 2002 | John J. Sickler Vice Chairman | 350.0K | 200.0K | — | — | — | 7.3K | 557.3K | 0.00% | ↗ |
| 185 | 2002 | Steven K. Chance Vice President, General Counsel | 280.0K | 110.0K | — | — | — | 9.4K | 399.4K | 0.00% | ↗ |
| 186 | 2002 | Roy C. Carriker Vice Chairman | 365.0K | — | — | — | — | 12.5K | 377.5K | 0.00% | ↗ |
| 187 | 2001 | Lennox K. Black Chairman and Director | 1.05M | — | — | — | — | 75.3K | 1.13M | 0.00% | ↗ |
| 188 | 2001 | Lennox K. Black Chairman, Chief Executive Officer | 1.05M | — | — | — | — | 75.3K | 1.13M | 0.00% | ↗ |
| 189 | 2001 | Jeffrey P. Black President, Chief Executive Officer | 421.5K | — | — | — | — | 6.0K | 427.5K | 0.00% | ↗ |
| 190 | 2001 | Roy C. Carriker Vice Chairman | 365.0K | — | — | — | — | 12.2K | 377.2K | 0.00% | ↗ |
| 191 | 2001 | Harold L. Zuber, Jr. Executive Vice President and Chief | 351.0K | — | — | — | — | 7.0K | 358.0K | 0.00% | ↗ |
| 192 | 2001 | John J. Sickler Vice Chairman | 350.0K | — | — | — | — | 4.4K | 354.4K | 0.00% | ↗ |
| 193 | 2001 | Steven K. Chance Vice President, General Counsel | 280.0K | — | — | — | — | 8.5K | 288.5K | 0.00% | ↗ |
| 194 | 2000 | Lennox K. Black Chairman, Chief Executive Officer | 976.0K | — | — | — | — | 1.07M | 2.05M | 0.00% | ↗ |
| 195 | 2000 | Harold L. Zuber, Jr. Executive Vice President and Chief | 330.0K | 200.0K | — | — | — | 4.7K | 534.7K | 0.00% | ↗ |
| 196 | 2000 | John J. Sickler Vice Chairman | 325.0K | 200.0K | — | — | — | 1.9K | 526.9K | 0.00% | ↗ |
| 197 | 2000 | Roy C. Carriker Vice Chairman | 346.6K | 160.0K | — | — | — | 4.1K | 510.7K | 0.00% | ↗ |
| 198 | 2000 | Jeffrey P. Black President, Chief Executive Officer | 230.0K | 140.0K | — | — | — | 3.1K | 373.1K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| John R. Deren | Executive Vice President & Chief Financial Officer | 824.6K | male |
| Daniel V. Logue | Corporate Vice President, General Counsel & Secretary | 694.9K | male |
| Cameron Hicks | Corporate Vice President & Chief Human Resources Officer | 664.0K | male |
| Stuart A. Randle | CEO, Interim President & Director | 113.5K | male |
| Kevin Robinson | President & GM of Anesthesia and Emergency Medicine | — | male |
| Lawrence Soren Keusch | Vice President of Investor Relations & Strategy Development | — | male |
| Matthew James | President & GM of Interventional | — | male |
| Michelle Fox | Corporate Vice President & Chief Medical Officer | — | female |
| Timothy F. Duffy | Vice President & Chief Information Officer | — | male |
| Howard Cyr | Corporate Vice President & Chief Compliance Officer | — | male |
| Jake Newman | President & GM of Vascular and Emergency Medicine | — | male |
| James Ferguson | President & GM of Surgical | — | male |
ESG Rating
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
| Transaction Date | Disclosed | Senator | State | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2014-11-10 | 2014-12-01 | Susan M. Collins | ME | Spouse | Purchase | $15,001 - $50,000 | ↗ |
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2025-07-22 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2025-07-16 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2025-02-25 | 2025-03-28 | Rob Bresnahan | PA08 | — | Sale | $1,001 - $15,000 | ↗ |
| 2023-10-02 | 2023-11-08 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2023-08-29 | 2023-09-06 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2023-07-12 | 2023-08-13 | Daniel Goldman | NY10 | — | Sale | $15,001 - $50,000 | ↗ |
| 2023-04-10 | 2023-05-19 | Daniel Goldman | NY10 | — | Purchase | $15,001 - $50,000 | ↗ |
| 2022-11-30 | 2022-12-29 | Susie Lee | NV03 | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2022-08-01 | 2022-09-08 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2022-05-10 | 2022-06-10 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2022-05-05 | 2022-06-10 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2022-02-14 | 2022-03-08 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2022-01-11 | 2022-02-08 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2021-06-28 | 2021-07-13 | Susie Lee | NV03 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2020-12-16 | 2021-01-11 | Susie Lee | NV03 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2020-12-08 | 2021-01-11 | Susie Lee | NV03 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2020-12-03 | 2021-01-11 | Susie Lee | NV03 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2020-05-19 | 2020-06-15 | Susie Lee | NV03 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-04-28 | 2020-06-15 | Susie Lee | NV03 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TFX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
